<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30873043</article-id>
<article-id pub-id-type="pmc">6400979</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2019.00141</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Kelly Q.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/573913/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Green</surname>
<given-names>Colin R.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/469570/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bennet</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/467982/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gunn</surname>
<given-names>Alistair J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/95372/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Davidson</surname>
<given-names>Joanne O.</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/251736/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Physiology, The University of Auckland</institution>, <addr-line>Auckland</addr-line>, <country>New Zealand</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Ophthalmology, The University of Auckland</institution>, <addr-line>Auckland</addr-line>, <country>New Zealand</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mary Tolcos, RMIT University, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Julie Wixey, University of Queensland, Australia; Meredith Anne Kelleher, Oregon Health &amp; Science University, United States</p>
</fn>
<corresp id="c001">*Correspondence: Joanne O. Davidson <email>joanne.davidson@auckland.ac.nz</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Embryonic and Developmental Physiology, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>141</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Zhou, Green, Bennet, Gunn and Davidson.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Zhou, Green, Bennet, Gunn and Davidson</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Perinatal brain injury remains a major cause of death and life-long disability. Perinatal brain injury is typically associated with hypoxia-ischemia and/or infection/inflammation. Both hypoxia-ischemia and infection trigger an inflammatory response in the brain. The inflammatory response can contribute to brain cell loss and chronic neuroinflammation leading to neurological impairments. It is now well-established that brain injury evolves over time, and shows a striking spread from injured to previously uninjured regions of the brain. There is increasing evidence that this spread is related to opening of connexin hemichannels and pannexin channels, both of which are large conductance membrane channels found in almost all cell types in the brain. Blocking connexin hemichannels within the first 3 h after hypoxia-ischemia has been shown to improve outcomes in term equivalent fetal sheep but it is important to also understand the downstream pathways linking membrane channel opening with the development of injury in order to identify new therapeutic targets. Open membrane channels release adenosine triphosphate (ATP), and other neuroactive molecules, into the extracellular space. ATP has an important physiological role, but has also been reported to act as a damage-associated molecular pattern (DAMP) signal mediated through specific purinergic receptors and so act as a primary signal 1 in the innate immune system inflammasome pathway. More crucially, extracellular ATP is a key inflammasome signal 2 activator, with purinergic receptor binding triggering the assembly of the multi-protein inflammasome complex. The inflammasome pathway and complex formation contribute to activation of inflammatory caspases, and the release of inflammatory cytokines, including interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-18, and vascular endothelial growth factor (VEGF). We propose that the NOD-like receptor protein-3 (NLRP3) inflammasome, which has been linked to inflammatory responses in models of ischemic stroke and various inflammatory diseases, may be one mechanism by which connexin hemichannel opening especially mediates perinatal brain injury.</p>
</abstract>
<kwd-group>
<kwd>connexin</kwd>
<kwd>pannexin</kwd>
<kwd>hemichannel</kwd>
<kwd>ischemia</kwd>
<kwd>inflammation</kwd>
<kwd>inflammasome</kwd>
<kwd>ATP</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Health Research Council of New Zealand<named-content content-type="fundref-id">10.13039/501100001505</named-content></funding-source>
<award-id rid="cn001">16/003</award-id>
<award-id rid="cn001">17/601</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Marsden Fund<named-content content-type="fundref-id">10.13039/501100009193</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="220"></ref-count>
<page-count count="21"></page-count>
<word-count count="18270"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Perinatal brain injury is associated with death or significant long-term neurodevelopmental impairment, affecting 1.15 million infants in the world in 2010 (Lee et al., <xref ref-type="bibr" rid="B107">2013</xref>). It affects both term and preterm infants (born &lt;37 weeks of completed gestation), with the greatest incidence in the most preterm infants (Larroque et al., <xref ref-type="bibr" rid="B106">2008</xref>). In term born infants, perinatal brain injury is most often linked to hypoxia-ischemia (HI) (Vannucci, <xref ref-type="bibr" rid="B186">2000</xref>; Shankaran et al., <xref ref-type="bibr" rid="B164">2005</xref>), where the incidence of moderate to severe hypoxic-ischemic encephalopathy (HIE) is ~1–3 in 1,000 live births (Edwards et al., <xref ref-type="bibr" rid="B54">2010</xref>). By contrast, in preterm infants, brain injury arises from the complex interaction of HI, infection/inflammation and preterm birth itself (Galinsky et al., <xref ref-type="bibr" rid="B70">2018b</xref>). Strikingly, ~50% of extremely preterm infants (born &lt;26 weeks of gestation) develop moderate to severe disability (Marlow et al., <xref ref-type="bibr" rid="B120">2005</xref>).</p>
<p>Currently, there is only one established neuroprotective treatment for term babies born with HIE, which is therapeutic hypothermia. Clinically, this treatment is only partially effective, with a number needed to treat of ~8, meaning of 8 treated infants with HIE, one additional infant will survive without moderate to severe disability (Gunn et al., <xref ref-type="bibr" rid="B81">2017</xref>; Natarajan et al., <xref ref-type="bibr" rid="B133">2018</xref>). However, there are currently no proven treatments to reduce brain damage for preterm infants with HIE or perinatal infection/inflammation. Therefore, there is significant interest in developing complementary or novel treatments for perinatal brain injury after HI or infection/inflammation. For term infants, it is important to develop interventions with additive benefit to therapeutic hypothermia, as it is now standard therapy. Novel treatments are needed for term and preterm infection/inflammation.</p>
<p>After HI, there is a striking evolution of injury which progresses over time from injured to previously uninjured regions of the brain (Azzopardi et al., <xref ref-type="bibr" rid="B4">1989</xref>; Thornton et al., <xref ref-type="bibr" rid="B180">1998</xref>). The mechanisms behind this spread are not well-understood. Increasing evidence supports the opening of cell membrane channels after HI as one of the mediators of this propagation of injury, particularly connexin hemichannels, which are the unopposed half of a gap junction, forming large conductance channels in the cell membrane (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>, <xref ref-type="bibr" rid="B40">2014</xref>; Wang et al., <xref ref-type="bibr" rid="B192">2014</xref>; Li et al., <xref ref-type="bibr" rid="B111">2015</xref>). Pannexin channels may also open under pathological conditions, although they appear to be tightly regulated (Qiu and Dahl, <xref ref-type="bibr" rid="B153">2009</xref>) and their role in the developing brain remains unclear. In this review, we examine the hypothesis that prolonged opening of connexin hemichannels leads to a cascade of injurious mechanism, potentially through inflammation by activation, amplification and perpetuation of the inflammasome pathway.</p>
<p>An inflammatory response is seen in perinatal brain injury after HI as well as infection/inflammation, and if chronic inflammation is established can have deleterious effects (Hagberg et al., <xref ref-type="bibr" rid="B83">2015</xref>; Bennet et al., <xref ref-type="bibr" rid="B13">2018</xref>). Hemichannels release adenosine triphosphate (ATP) (Kang et al., <xref ref-type="bibr" rid="B97">2008</xref>; Chekeni et al., <xref ref-type="bibr" rid="B26">2010</xref>; Orellana et al., <xref ref-type="bibr" rid="B141">2011</xref>; Bennett et al., <xref ref-type="bibr" rid="B15">2012</xref>), which may act as a damage associated molecular pattern (DAMP), but is also a key inflammasome activator signal. The release of ATP through connexin hemichannels can perpetuate inflammation through purinergic signaling (Pedata et al., <xref ref-type="bibr" rid="B148">2016</xref>). Purinergic signaling has been associated with the activation of microglia (Li et al., <xref ref-type="bibr" rid="B110">2011</xref>; Kaiser et al., <xref ref-type="bibr" rid="B96">2016</xref>) and the inflammasome complex—a multi-protein complex involved in initiating an innate immune system inflammatory response (Feng et al., <xref ref-type="bibr" rid="B57">2015</xref>). This review will dissect the evidence for these pathways downstream of connexin hemichannel and pannexin channel opening and how they contribute to inflammation. One other membrane pore forming protein, Gasdermin D, has been implicated in the inflammasome pathway (Groslambert and Py, <xref ref-type="bibr" rid="B79">2018</xref>; Kerur et al., <xref ref-type="bibr" rid="B100">2018</xref>), but that channel is very small in comparison with the pannexin and connexin channels and appears to be primarily associated with apoptosis. As will become evident in this review, both <italic>in vitro</italic> and animal studies using connexin hemichannel or pannexin channel blockers, would suggest that other channels are likely to play minor roles in relation to ATP release, and inflammasome activation in particular.</p>
</sec>
<sec id="s2">
<title>Evolution of Injury</title>
<p>Perinatal brain injury after HI is an evolving process that can be characterized into four phases (Bennet et al., <xref ref-type="bibr" rid="B12">2010</xref>; Davidson et al., <xref ref-type="bibr" rid="B45">2015b</xref>). The primary phase of injury occurs during the HI insult itself, when the failure of oxidative metabolism results in anoxic depolarization, edema and necrosis (Wassink et al., <xref ref-type="bibr" rid="B196">2018</xref>). After restoration of blood flow and oxygen supply, there is a period of apparent transient recovery when oxidative metabolism is at least partially restored, known as the latent phase (Davidson et al., <xref ref-type="bibr" rid="B38">2018a</xref>). However, the latent phase is the key time when the deleterious mechanisms leading to the spread of brain injury may be initiated; for example, the opening of connexin hemichannels, which will be discussed further below (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>).</p>
<p>Following the latent phase, there is a delayed (“secondary”) deterioration of oxidative metabolism starting ~6–15 h after the insult (Azzopardi et al., <xref ref-type="bibr" rid="B4">1989</xref>; Williams et al., <xref ref-type="bibr" rid="B201">1991</xref>; Gunn et al., <xref ref-type="bibr" rid="B80">1997</xref>). This phase is characterized by delayed cerebral energy failure followed by seizures and secondary cell swelling (Bennet et al., <xref ref-type="bibr" rid="B14">2006</xref>; Davidson et al., <xref ref-type="bibr" rid="B46">2015c</xref>). There is marked neuronal injury after HI at term, with the majority of neuronal loss occurring during the secondary phase, through a continuum of necrosis-apoptosis and autophagy (Northington et al., <xref ref-type="bibr" rid="B139">2007</xref>, <xref ref-type="bibr" rid="B138">2011</xref>).</p>
<p>The tertiary phase is a period of repair and reorganization, persisting for weeks to years after the initial insult (Fleiss and Gressens, <xref ref-type="bibr" rid="B59">2012</xref>). During this period, surviving cells in the brain can rewire, but there may be a low level of ongoing cell death due to the loss of trophic support and problems with connectivity (Ness et al., <xref ref-type="bibr" rid="B136">2001</xref>; Romanko et al., <xref ref-type="bibr" rid="B157">2004</xref>). Long-term impairment in perinatal brain injury may also be associated with epigenetic changes (Fleiss and Gressens, <xref ref-type="bibr" rid="B59">2012</xref>), but also persistent inflammation (Bennet et al., <xref ref-type="bibr" rid="B13">2018</xref>) as reported for other types of brain injury and degenerative diseases (Patterson and Holahan, <xref ref-type="bibr" rid="B146">2012</xref>; Freeman and Ting, <xref ref-type="bibr" rid="B63">2016</xref>).</p>
</sec>
<sec id="s3">
<title>Inflammation in Perinatal Brain Injury</title>
<p>Perinatal brain injury associated with HI or infection/inflammation can trigger an inflammatory response. The innate immune response is the body's first line of defense against pathogens, reacting rapidly following exposure to invading organisms (Medzhitov, <xref ref-type="bibr" rid="B123">2007</xref>). As part of the innate immune response, pattern recognition receptors (PRRs) expressed on immune cells recognize both the conserved molecular structures found on the pathogen known as pathogen-associated molecular patterns (PAMPs), and the endogenous signals released by damaged tissues known as danger-associated molecular patterns (DAMPs) (Medzhitov, <xref ref-type="bibr" rid="B123">2007</xref>; Takeuchi and Akira, <xref ref-type="bibr" rid="B175">2010</xref>).</p>
<p>The activation of PRRs initiates the inflammatory response leading to release of inflammatory cytokines, such as interleukin (IL)-1β (Turner et al., <xref ref-type="bibr" rid="B183">2014</xref>). This early phase of inflammation targets the invading pathogens and/or clears injured tissue, which is beneficial to the host. However, this inflammatory response also leads to the death of uninjured neural cells in a process known as “bystander cell loss” (Hagberg et al., <xref ref-type="bibr" rid="B83">2015</xref>). It is believed that the initial pro-inflammatory response is followed by anti-inflammatory and reparative processes, and either eventual resolution of inflammation or chronic inflammation (Gilroy and De Maeyer, <xref ref-type="bibr" rid="B73">2015</xref>; Hagberg et al., <xref ref-type="bibr" rid="B83">2015</xref>).</p>
<p>Elevated levels of inflammatory markers after birth are associated with adverse neurodevelopmental outcomes. A prospective cohort study of 73 term infants exposed to perinatal asphyxia showed that those who died or were diagnosed with cerebral palsy at a 1 year follow up, were associated with higher levels of IL-1, IL-6 and tumor necrosis factor (TNF)-α in heel-stick blood samples collected on the first or second day of birth (Foster-Barber et al., <xref ref-type="bibr" rid="B60">2001</xref>). In the same cohort, followed up at 30 months of age, those with higher serum cytokine levels of IL-1β, IL-6, and IL-8 at birth were associated with abnormal cognitive and motor outcomes (Bartha et al., <xref ref-type="bibr" rid="B11">2004</xref>). The extremely low gestational age newborns (born before 28 weeks of gestation) (ELGANs) study is a large multi-center observational study. In this cohort, elevated blood concentrations of inflammatory proteins, measured in the first few weeks of life was associated with mental and motor impairments at 2 years old (O'Shea et al., <xref ref-type="bibr" rid="B143">2012</xref>) and adverse cognitive outcome at 10 years of age (Kuban et al., <xref ref-type="bibr" rid="B104">2017</xref>), as well as increased risk of behavioral problems, including autism (Korzeniewski et al., <xref ref-type="bibr" rid="B103">2018</xref>). Cytokine levels were not measured at later time points to determine if inflammation was sustained. However, a study by Lin and colleagues has suggested that perinatal brain injury is associated with long-lasting alterations to the inflammatory response (Lin et al., <xref ref-type="bibr" rid="B112">2010</xref>). Peripheral blood mononuclear cells from a small cohort of preterm born children with periventricular leukomalacia induced cerebral palsy, were shown to have higher mRNA levels of inflammatory molecules, both before and after lipopolysaccharide (LPS) stimulation (Lin et al., <xref ref-type="bibr" rid="B112">2010</xref>). Non-resolving inflammation could be the result of a prolonged or excessive inflammatory response, which may lead to the disruption of pathways that normally induce inflammatory resolution (Nathan and Ding, <xref ref-type="bibr" rid="B134">2010</xref>; Bennet et al., <xref ref-type="bibr" rid="B13">2018</xref>).</p>
</sec>
<sec id="s4">
<title>Connexin Hemichannels</title>
<p>Connexin gap junctions connect the intracellular space of two adjacent cells allowing for the exchange of ions and molecules (Kumar and Gilula, <xref ref-type="bibr" rid="B105">1996</xref>; Alexander and Goldberg, <xref ref-type="bibr" rid="B1">2003</xref>; Davidson et al., <xref ref-type="bibr" rid="B41">2013a</xref>). A connexin hemichannel is comprised of six connexin subunits. Connexin hemichannels from adjacent cells dock together to form a gap junction (Unger et al., <xref ref-type="bibr" rid="B184">1999</xref>; Davidson et al., <xref ref-type="bibr" rid="B41">2013a</xref>; Leybaert et al., <xref ref-type="bibr" rid="B109">2017</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). Humans have 21 connexin genes, and 11 of these are expressed in the brain (Theis et al., <xref ref-type="bibr" rid="B177">2005</xref>). Connexin 43 (Cx43) has been of particular interest in the brain as it is abundantly expressed, especially in astrocytes, microglia and microvascular endothelium (Dermietzel et al., <xref ref-type="bibr" rid="B51">2000</xref>; Nagy et al., <xref ref-type="bibr" rid="B129">2003</xref>; Davidson et al., <xref ref-type="bibr" rid="B41">2013a</xref>). Under physiological conditions, prior to forming a gap junction, hemichannels at the cell surface have a low probability of opening, shown by low membrane permeability during resting conditions in cultured cells (Decrock et al., <xref ref-type="bibr" rid="B49">2009</xref>). It is not known whether this is the case <italic>in vivo</italic>, as cells may be exposed to a wide range of stimuli influencing hemichannel opening (Sáez et al., <xref ref-type="bibr" rid="B161">2005</xref>). When hemichannels do open though, they form a large non-selective membrane channel capable of passing molecules up to about 1 kDa in size (Evans et al., <xref ref-type="bibr" rid="B56">2006</xref>). There is increasing evidence that dysregulated hemichannel opening can be detrimental and they are often referred to as “pathological pores” (Paul et al., <xref ref-type="bibr" rid="B147">1991</xref>; Decrock et al., <xref ref-type="bibr" rid="B48">2015</xref>; Willebrords et al., <xref ref-type="bibr" rid="B200">2016</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Schematic depicting the Connexin 43 (Cx43) gap junction and hemichannel and pannexin 1 (Px1) channel. A connexon consists of six connexin subunits. A Cx43 gap junction is made up of two opposing connexons, each contributed from two adjacent cells. A Cx43 hemichannel is an unopposed connexon. A Px1 channel is formed by six pannexin subunits. Px1 does not form gap junctions due to N-linked glycosylation on the extracellular loop.</p>
</caption>
<graphic xlink:href="fphys-10-00141-g0001"></graphic>
</fig>
<p>Connexin hemichannels are involved in the spread of brain injury after HI or infection in the adult and immature brain (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>, <xref ref-type="bibr" rid="B41">2013a</xref>) (studies are summarized in <xref ref-type="table" rid="T1">Table 1</xref>). They open in response to stimuli mimicking exposure to ischemia and inflammation <italic>in vitro</italic>. For example, in cultured cells, oxygen-glucose deprivation (OGD), metabolic inhibition, low extracellular Ca<sup>2+</sup>, and strong depolarization have all been proven to stimulate hemichannel opening (Contreras et al., <xref ref-type="bibr" rid="B34">2002</xref>; Decrock et al., <xref ref-type="bibr" rid="B49">2009</xref>; Orellana et al., <xref ref-type="bibr" rid="B142">2010</xref>). Conditioned medium from LPS-activated microglia or TNF-α and IL-1β increased hemichannel activity in cultured astrocytes (Retamal et al., <xref ref-type="bibr" rid="B154">2007</xref>). In addition, neuroinflammation induced by S. aureus intracerebral inoculation increased Cx43 hemichannel activity in astrocytes surrounding the abscess (Karpuk et al., <xref ref-type="bibr" rid="B98">2011</xref>). The opening of connexin hemichannels allows for the influx of Na<sup>+</sup>, Cl<sup>−</sup>, and Ca<sup>2+</sup> and the efflux of K<sup>+</sup> ions. This increases cell permeability, leading to the depolarization of the cell, and cell lysis (Paul et al., <xref ref-type="bibr" rid="B147">1991</xref>; Gómez-Hernández et al., <xref ref-type="bibr" rid="B75">2003</xref>). Molecules, such as ATP, glutamate and aspartate can be released; all of these molecules are associated with injury (Ye et al., <xref ref-type="bibr" rid="B212">2003</xref>; Gomes et al., <xref ref-type="bibr" rid="B74">2005</xref>; Zhao et al., <xref ref-type="bibr" rid="B220">2005</xref>; Kang et al., <xref ref-type="bibr" rid="B97">2008</xref>). Additionally, Cx43 hemichannels are likely involved in the propagation of seizures following severe HI in near-term fetal sheep (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Summary of studies of Cx43 hemichannels and Px1 channels and purinergic receptors P2X4 and P2X7.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Species</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Age</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Paradigm</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Hemichannel activity/expression</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Drug/knockout</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Drug/knockout effect</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Connexin 43 (Cx43)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat primary astrocyte culture</td>
<td align="left" colspan="1" rowspan="1" valign="top">Embyronic day (E) 9</td>
<td align="left" colspan="1" rowspan="1" valign="top">Metabolic inhibition</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Cx43 hemichannel opening during metabolic inhibition</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Contreras et al., <xref ref-type="bibr" rid="B34">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat primary astrocyte culture</td>
<td align="left" colspan="1" rowspan="1" valign="top">P1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Conditioned medium from LPS-activated microglia or TNF-α and IL-1β</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Cx43 hemichannel activity 24 h after treatment</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Retamal et al., <xref ref-type="bibr" rid="B154">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat primary astrocyte culture</td>
<td align="left" colspan="1" rowspan="1" valign="top">P1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoxia and artificial cerebrospinal fluid medium mimicking ischemic conditions</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Cx43 hemichannel opening 1 h after reoxygenation</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Orellana et al., <xref ref-type="bibr" rid="B142">2010</xref><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Human microvascular endothelial cells</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoxic acidic ion-shifted ringer solution</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ ATP release from Cx43 hemichannels during treatment and after reperfusion</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Kim and Green, <xref ref-type="bibr" rid="B101">2016</xref><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">C6 glioma cells transfected with Cx43</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Voltage activation of Cx43 hemichannels</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ ATP release from Cx43 hemichannels</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Kang et al., <xref ref-type="bibr" rid="B97">2008</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Human adult retinal pigment epithelial cells</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">High glucose, TNF-α and IL-1β</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ ATP release from Cx43 hemichannels</td>
<td align="left" colspan="1" rowspan="1" valign="top">Peptide 5 (5–50 μM), administered at the same time as high glucose and cytokine treatment</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ NLRP3 oligomerization<break></break>↓ Cytokine release</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mugisho et al., <xref ref-type="bibr" rid="B128">2018</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse acute brain slice</td>
<td align="left" colspan="1" rowspan="1" valign="top">8–12 weeks</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>S. aureus in vivo</italic> intracerebral inoculation</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Cx43 hemichannel activity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Karpuk et al., <xref ref-type="bibr" rid="B98">2011</xref><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Sheep</td>
<td align="left" colspan="1" rowspan="1" valign="top">Near-term</td>
<td align="left" colspan="1" rowspan="1" valign="top">Carotid artery occlusion</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ mRNA expression (6 h after end of occlusion)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Peptide5 i.c.v. (50 μmol/kg over 1 h, then 50 μmol/kg over 24 h) started 90 min after end of occlusion</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Neuronal and oligodendrocyte survival<break></break>Improved electroencephalogram recovery<break></break>↓ Seizure burden</td>
<td align="left" colspan="1" rowspan="1" valign="top">Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>; Galinsky et al., <xref ref-type="bibr" rid="B69">2017</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Sheep</td>
<td align="left" colspan="1" rowspan="1" valign="top">Near-term</td>
<td align="left" colspan="1" rowspan="1" valign="top">Carotid artery occlusion</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Peptide5 i.c.v. (50 μmol/kg over 1 h, then 50 μmol/kg over 24 h) started 3 h after end of occlusion</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Seizure burden</td>
<td align="left" colspan="1" rowspan="1" valign="top">Davidson et al., <xref ref-type="bibr" rid="B44">2015a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Sheep</td>
<td align="left" colspan="1" rowspan="1" valign="top">Near-term</td>
<td align="left" colspan="1" rowspan="1" valign="top">Carotid artery occlusion</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Peptide5 i.c.v. (50 μmol/kg/h) given 1 h before, and during occlusion only</td>
<td align="left" colspan="1" rowspan="1" valign="top">No neuroprotection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Davidson et al., <xref ref-type="bibr" rid="B42">2013b</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Sheep</td>
<td align="left" colspan="1" rowspan="1" valign="top">Preterm</td>
<td align="left" colspan="1" rowspan="1" valign="top">Umbilical cord occlusion</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Peptide5 i.c.v. (50 μmol/kg over 1 h, then 50 μmol/kg over 24 h) started 90 min after end of occlusion</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Neuronal and oligodendrocyte<break></break>Improved electroencephalogram recovery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Davidson et al., <xref ref-type="bibr" rid="B41">2013a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">P7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Common carotid artery ligation and hypoxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression (24–48 h after HI)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Wang et al., <xref ref-type="bibr" rid="B192">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">P7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Common carotid artery ligation and hypoxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression (8 h to 7 d after HI)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gap 26 i.p. (50 μg/kg, 1 h) before HI</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Infarct size<break></break>↑ Motor and memory scores</td>
<td align="left" colspan="1" rowspan="1" valign="top">Li et al., <xref ref-type="bibr" rid="B111">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">P10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acute hypoxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">No change (10 min to 35 d after HI)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Zeinieh et al., <xref ref-type="bibr" rid="B219">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Pannexin 1</bold>
<break></break>
<bold>(Px1)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat primary neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">P20-25</td>
<td align="left" colspan="1" rowspan="1" valign="top">N-methyl-D-aspartate receptor (NMDAR) activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Px1 channel opening</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Thompson et al., <xref ref-type="bibr" rid="B178">2008</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat primary neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">P15-20</td>
<td align="left" colspan="1" rowspan="1" valign="top">OGD</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Px1 channel opening during OGD</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Thompson et al., <xref ref-type="bibr" rid="B179">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse hippocampal slice</td>
<td align="left" colspan="1" rowspan="1" valign="top">P13-14</td>
<td align="left" colspan="1" rowspan="1" valign="top">High K<sup>+</sup> medium</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Px1 channel opening</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Santiago et al., <xref ref-type="bibr" rid="B162">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse primary astrocytes</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">OGD</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Probenecid (10 μM)</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ IL-1β release<break></break>↓ NLRP3 protein expression</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jian et al., <xref ref-type="bibr" rid="B93">2016</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse acute brain slice</td>
<td align="left" colspan="1" rowspan="1" valign="top">8–12 weeks</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>S. aureus in vivo</italic> intracerebral inoculation</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Px1 channel activity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Karpuk et al., <xref ref-type="bibr" rid="B98">2011</xref><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Xenopus oocytes expressing Px1</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">High K<sup>+</sup> medium</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ ATP release during treatment from Px1 channels</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Bao et al., <xref ref-type="bibr" rid="B8">2004</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat primary astrocyte culture</td>
<td align="left" colspan="1" rowspan="1" valign="top">P1/2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoxia and artificial cerebrospinal fluid medium mimicking ischemic conditions</td>
<td align="left" colspan="1" rowspan="1" valign="top">No Px1 channel opening at 1 h after reoxygenation</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Orellana et al., <xref ref-type="bibr" rid="B142">2010</xref><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Human microvascular endothelial cells</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoxic acidic ion-shifted ringer solution</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ ATP release from Px1 channels during treatment but not after reperfusion</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Kim and Green, <xref ref-type="bibr" rid="B101">2016</xref><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mefloquine i.p. (1 mg/kg/d) given during the start of MCAO</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Infarction size<break></break>↑ Motor scores<break></break><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref> No additive effect with P2X7R blockade</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cisneros-Mejorado et al., <xref ref-type="bibr" rid="B32">2015a</xref><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Probencid (i.v., 2 mg/kg) given before reperfusion</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Neuronal survival</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wei et al., <xref ref-type="bibr" rid="B198">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Px1 protein expression in females vs. male on ischemic and non-ischemic hemispheres</td>
<td align="left" colspan="1" rowspan="1" valign="top">Probenicid i.p. (250 mg/kg) at 1.5 and 5 h</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Infarct volume (female only)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Freitas-Andrade et al., <xref ref-type="bibr" rid="B64">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Purinergic receptor (P2X4R)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat hippocampal slice</td>
<td align="left" colspan="1" rowspan="1" valign="top">P8-10</td>
<td align="left" colspan="1" rowspan="1" valign="top">OGD</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression at 24 h</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Cavaliere et al., <xref ref-type="bibr" rid="B23">2003</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression at 6, 24, and 72 h</td>
<td align="left" colspan="1" rowspan="1" valign="top">Global P2X4R knockout<break></break>Myeloid cell P2X4R knockout</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Infarct volume<break></break>↓ IL-1β and TNF-α release<break></break>↓ Infarct volume<break></break>(females only)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Verma et al., <xref ref-type="bibr" rid="B187">2017</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat primary microglia</td>
<td align="left" colspan="1" rowspan="1" valign="top">P2-3</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">TNP-ATP (20 μM)</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Change of microglia to rounded morphology<break></break>↓ IL-1β and TNF-α protein expression</td>
<td align="left" colspan="1" rowspan="1" valign="top">Li et al., <xref ref-type="bibr" rid="B110">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">P0</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression from 4 h to 14 d</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Li et al., <xref ref-type="bibr" rid="B110">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">P3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Common carotid artery occlusion and hypoxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression 5 and 7 d after HI</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Wixey et al., <xref ref-type="bibr" rid="B205">2009</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Puringeric receptor (P2X7R)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuronal culture</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">OGD</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Brilliant Blue G (50 nM or 5 μM) during OGD</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Cell death</td>
<td align="left" colspan="1" rowspan="1" valign="top">Arbeloa et al., <xref ref-type="bibr" rid="B2">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Brilliant Blue G i.p. (30 mg/kg) during MCAO</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Neuronal loss<break></break>↓ Infarct volume</td>
<td align="left" colspan="1" rowspan="1" valign="top">Arbeloa et al., <xref ref-type="bibr" rid="B2">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">P0</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intrauterine asphyxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression immediately after asphyxia</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Frizzo et al., <xref ref-type="bibr" rid="B66">2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression 4 d after MCAO</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Franke et al., <xref ref-type="bibr" rid="B62">2004</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">Common carotid and vertebral arteries occlusion</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression from 6 h to 7 d after insult</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brilliant Blue G treatment i.v. (50 mg/kg) administered daily, for 3 d immediately after occlusion</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Neuronal loss</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yu et al., <xref ref-type="bibr" rid="B217">2013</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">A-438079 (3 μg, i.c.v.) or Brilliant Blue G (10 μg, i.c.v.), or Oxidized ATP (1 μg, i.c.v.), prior to HI</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Neuronal loss<break></break>↑ Motor performance</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chu et al., <xref ref-type="bibr" rid="B30">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> expression of P2X7R on microglia</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Melani et al., <xref ref-type="bibr" rid="B124">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intracerebral hemorrhage</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">P2X7R siRNA i.c.v. (1,000 pmol)</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ NLRP3 inflammasome activation<break></break>↓ IL-1β and IL-18 release</td>
<td align="left" colspan="1" rowspan="1" valign="top">Feng et al., <xref ref-type="bibr" rid="B57">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuronal culture</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">OGD</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression after 3, 6, and 12 h of OGD</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Ye et al., <xref ref-type="bibr" rid="B211">2017</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">Photothrombotic cerebral ischemia</td>
<td align="left" colspan="1" rowspan="1" valign="top">↑ Protein expression from 1 to 5 d after insult</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brilliant Blue G (45.5 mg/kg, i.p.) given at 1, 3, and 5 d</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Infarct volume<break></break>↓ Protein expression of NLRP3, ASC, and caspase 1 p20</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ye et al., <xref ref-type="bibr" rid="B211">2017</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Brilliant Blue G (30 mg/kg twice per day, i.p.) during MCAO</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Infarction size<break></break>↑ Motor scores<break></break><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref> No additive effect with Px1 blockade</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cisneros-Mejorado et al., <xref ref-type="bibr" rid="B32">2015a</xref><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAO</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">P2X7R knockout</td>
<td align="left" colspan="1" rowspan="1" valign="top">↓ Microglia activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kaiser et al., <xref ref-type="bibr" rid="B96">2016</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>*</label>
<p><italic>Studies that report interactions between connexin hemichannels, pannexin channels, and/or purinergic receptors</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>An upregulation of Cx43 has been shown to occur in adult and perinatal animals after HI and in adult human post-mortem studies of cerebral ischemia (Nakase et al., <xref ref-type="bibr" rid="B132">2006</xref>, <xref ref-type="bibr" rid="B131">2009</xref>; Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>; Wang et al., <xref ref-type="bibr" rid="B192">2014</xref>; Li et al., <xref ref-type="bibr" rid="B111">2015</xref>). The timing of this Cx43 increase varies between studies, with Cx43 mRNA levels significantly increased at 6 h after carotid artery occlusion in near-term fetal sheep (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>). Protein levels progressively increased in the ischemic region from 8 h to 7 days after common carotid artery ligation and hypoxia (commonly referred to as Rice-Vannucci model of HI) in post-natal day (P)7 rats (equivalent to 33–34 weeks of human brain maturation) (Li et al., <xref ref-type="bibr" rid="B111">2015</xref>). In the subventricular zone, however, Wang and colleagues reported Cx43 protein expression was only significantly increased from 24 h after the same insult in P7 rats (Wang et al., <xref ref-type="bibr" rid="B192">2014</xref>). However, there was no change in hippocampal Cx43 protein expression at all time-points between 10 min and 35 days after acute hypoxia in P10 rats (equivalent to human term brain maturation) (Zeinieh et al., <xref ref-type="bibr" rid="B219">2010</xref>). Thus, the changes in Cx43 expression may be dependent on species, brain region, type and/or severity of insult. It should be noted that, the Rice-Vannucci model of HI in rodents produces a unilateral infarction in the brain but only moderate systemic hypoxia (Rice et al., <xref ref-type="bibr" rid="B155">1981</xref>), whereas bilateral carotid artery occlusion in near-term fetal sheep produces a global cerebral insult resulting in a watershed pattern of brain injury, without systemic hypoxia (Williams et al., <xref ref-type="bibr" rid="B202">1992</xref>). The reader should note that protein assays and immunohistochemical labeling do not allow ready discrimination between gap junctions and hemichannels, or channel function.</p>
<p>The blockade of Cx43 hemichannels, however, has been neuroprotective in a variety of different animal models of perinatal HI (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>, <xref ref-type="bibr" rid="B40">2014</xref>; Li et al., <xref ref-type="bibr" rid="B111">2015</xref>). Intracerebroventricular (i.c.v.) infusion (50 μmol/kg over 1 h, then 50 μmol/kg over 24 h) of the Cx43 mimetic peptide—Peptide5, started at 90 min after the end of carotid artery occlusion in near-term fetal sheep, was associated with improved neuronal and oligodendrocyte survival and, electroencephalogram (EEG) recovery and reduced seizure burden (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>). Similarly, Peptide5 infusion following the same protocol as above in preterm fetal sheep after umbilical cord occlusion improved EEG recovery and reduced neuronal and oligodendrocyte loss (Davidson et al., <xref ref-type="bibr" rid="B40">2014</xref>). Reduced infarct size and improved motor and memory scores were observed in Gap 26 treated P7 rats [a connexin mimetic peptide which blocks hemichannels and gap junctions (Wang et al., <xref ref-type="bibr" rid="B194">2013</xref>)], given i.p., 50 μg/kg, 1 h before HI (Li et al., <xref ref-type="bibr" rid="B111">2015</xref>).</p>
<p>Cx43 hemichannel opening <italic>in vivo</italic> has been shown to occur after ischemia (in the latent phase), but not during ischemia. Pre-administration of Peptide5 was not neuroprotective when given 1 h before and during ischemia, but was neuroprotective when given after ischemia (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>, <xref ref-type="bibr" rid="B42">2013b</xref>). Supporting this, hemichannels in astrocyte cultures subjected to OGD have been shown to open 1 h after OGD (Orellana et al., <xref ref-type="bibr" rid="B142">2010</xref>). In addition, carbenoxolone (100 μmol/L) inhibition of connexin hemichannels did not attenuate ATP release during OGD in hippocampal slices (Frenguelli et al., <xref ref-type="bibr" rid="B65">2007</xref>). Both Cx43 hemichannel and pannexin channel opening was reported to occur during hypoxia in endothelial cells with two thirds of ATP release connexin hemichannel mediated, but upon reperfusion, only Cx43 hemichannel opening occurred (Kim and Green, <xref ref-type="bibr" rid="B101">2016</xref>). These studies indicate that Cx43 hemichannels likely do open after ischemia and may have an ongoing role in the evolution of injury after the insult. This is supported by the demonstration that prolonged infusion of Peptide5 (i.c.v., starting at 90 min) at a dose of 50 μmol/kg over 1 h, then 50 μmol/kg over 24 h of Peptide5 provided greater neuroprotection compared to a 1 h infusion only (50 μmol/kg) (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>). Furthermore, delayed administration of another known hemichannel blocker, Gap 26 (i.p., 50 μmol/kg) at 24 h after HI still had neuroprotective effects (Li et al., <xref ref-type="bibr" rid="B111">2015</xref>). Interestingly, when Peptide5 administration (i.c.v., 50 μmol/kg for 1 h followed by 50 μmol/kg for 24 h) was delayed until 3 h after the end of ischemia in near-term fetal sheep, the neuroprotective effects were reduced when compared to earlier administration (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>, <xref ref-type="bibr" rid="B44">2015a</xref>). The delayed administration reduced the seizure burden, but there was no clear effect on cell survival or EEG recovery (Davidson et al., <xref ref-type="bibr" rid="B43">2012</xref>, <xref ref-type="bibr" rid="B44">2015a</xref>).</p>
<p>The mechanisms behind how Cx43 hemichannels lead to neuronal and oligodendrocyte loss in HI is not well-understood. During and/or after HI there is impaired intracellular Ca<sup>2+</sup> handling. This has been shown to contribute to mitochondrial dysfunction and necrotic and apoptotic cell death (Puka-Sundvall et al., <xref ref-type="bibr" rid="B152">2000</xref>; Mallard et al., <xref ref-type="bibr" rid="B116">2014</xref>). Potentially, the opening of hemichannels could lead to an influx of excessive intracellular Ca<sup>2+</sup> accumulation leading directly to the neuronal and/or oligodendrocyte death (Galinsky et al., <xref ref-type="bibr" rid="B68">2018a</xref>). In support, GABAergic striatal neurons expressing intracellular calcium binding proteins are shown to be highly susceptible to HI injury in near-term fetal sheep (Galinsky et al., <xref ref-type="bibr" rid="B69">2017</xref>).</p>
<p>ATP has been widely associated with both inflammasome signal 1 priming which results in transcriptional upregulation of pro-IL-1β and pro-IL-18 and molecules in the inflammasome pathway itself, and inflammasome signal 2 activation that results in assembly of the NLRP3-ASC-pro-caspase1 inflammasome complex within the cell cytoplasm, and activation of caspase 1. Cx43 hemichannel mediated ATP release in particular has been associated with NOD-like receptor protein-3 (NLRP3) inflammasome complex assembly as shown in retinal pigment epithelial cells (Mugisho et al., <xref ref-type="bibr" rid="B128">2018</xref>), and with inflammasome activation <italic>in vivo</italic> in a model of chronic pain (Tonkin et al., <xref ref-type="bibr" rid="B182">2018</xref>). Neuron and oligodendrocyte damage after perinatal brain injury may also be due to this innate immune system inflammatory response, and is discussed further in section Activation of the Inflammasome below.</p>
</sec>
<sec id="s5">
<title>Pannexin Channels</title>
<p>Pannexin channels may have similar functions to connexin hemichannels, but their role in perinatal brain injury is not well-understood. Pannexins share homology with the gap junction proteins in invertebrates called innexins (Panchin, <xref ref-type="bibr" rid="B145">2005</xref>), and have a similar topological structure to connexins, despite not sharing sequence homology (Panchin, <xref ref-type="bibr" rid="B145">2005</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). Unlike connexins, pannexins have N-glycosylation on the extracellular loop, which appears to prevent the formation of cell-cell junctions (Boassa et al., <xref ref-type="bibr" rid="B17">2007</xref>) although there is some evidence for pannexin junction formation in C2C12 cells in culture (Ishikawa et al., <xref ref-type="bibr" rid="B90">2011</xref>). There are three subtypes of pannexin, of which pannexin 1 (Px1) and pannexin 2 (Px2) are found to be expressed in the adult and developing brain (Bruzzone et al., <xref ref-type="bibr" rid="B21">2003</xref>; Vogt et al., <xref ref-type="bibr" rid="B188">2005</xref>). Px1 is predominantly expressed in the plasma membrane, whereas Px2 is mainly expressed in intracellular membranes (Boassa et al., <xref ref-type="bibr" rid="B17">2007</xref>).</p>
<p>Opening of pannexin channels can be induced by a range of stimuli <italic>in vitro</italic>—including OGD, high extracellular K<sup>+</sup> concentration, hypoglycemia, cell swelling and the stimulation of NMDA receptors (Thompson et al., <xref ref-type="bibr" rid="B179">2006</xref>, <xref ref-type="bibr" rid="B178">2008</xref>; Kawamura et al., <xref ref-type="bibr" rid="B99">2010</xref>; Santiago et al., <xref ref-type="bibr" rid="B162">2011</xref>). Px1 channels are permeable to ions, and molecules, such as ATP and glucose (Bruzzone et al., <xref ref-type="bibr" rid="B21">2003</xref>; Bao et al., <xref ref-type="bibr" rid="B8">2004</xref>; Riquelme et al., <xref ref-type="bibr" rid="B156">2013</xref>) and the opening of Px1 channels contributes to anoxic depolarization, which can lead to cell death (Thompson et al., <xref ref-type="bibr" rid="B178">2008</xref>; Weilinger et al., <xref ref-type="bibr" rid="B199">2012</xref>). In astrocytes on the border of abscess regions caused by S. aureus intracerebral inoculation in mice, there is increased Cx43 hemichannel and Px1 channel activity (Karpuk et al., <xref ref-type="bibr" rid="B98">2011</xref>). Increased Px1 channel activity in apoptotic lymphocytes <italic>in vitro</italic> has been associated with providing “find me” signals through ATP release to attract macrophages (Chekeni et al., <xref ref-type="bibr" rid="B26">2010</xref>). In addition, Px1 channel opening has been linked to the activation of the NLRP3 inflammasome and IL-1β release in astrocytes subjected to OGD (Jian et al., <xref ref-type="bibr" rid="B93">2016</xref>).</p>
<p>In adult rodent models of stroke, blocking Px1 has neuroprotective effects (Cisneros-Mejorado et al., <xref ref-type="bibr" rid="B32">2015a</xref>; Wei et al., <xref ref-type="bibr" rid="B198">2015</xref>; Freitas-Andrade et al., <xref ref-type="bibr" rid="B64">2017</xref>). However, to the best of our knowledge, the effect of Px1 blockade after HI has not been examined in the developing brain. Mefloquine (Px1 blocker) injections given during the start of middle cerebral artery occlusion (MCAO) (i.p., 1 mg/kg/day) in adult mice reduced infarction size and improved motor scores (Cisneros-Mejorado et al., <xref ref-type="bibr" rid="B32">2015a</xref>). It should be noted, however, that mefloquine may also inhibit connexin hemichannel opening (Cruikshank et al., <xref ref-type="bibr" rid="B36">2004</xref>). The effectiveness of Px1 blockade is time dependent, as the administration of probenecid, another non-specific Px1 blocker, was most protective against the death of hippocampal CA1 neurons when given before reperfusion (i.v., 2 mg/kg) in adult rats subjected to MCAO (Wei et al., <xref ref-type="bibr" rid="B198">2015</xref>). There was partial protection when administered at 2 h, but no effect when delayed until 6 h after the insult (Wei et al., <xref ref-type="bibr" rid="B198">2015</xref>). Probenecid administration for 7 days starting at 6 h, however, was more protective than a single dose at 6 h. There was also reduced inflammation, shown by reduced astrocytic and microglial immunoreactivity (Wei et al., <xref ref-type="bibr" rid="B198">2015</xref>). The role of Px1 may also be sex dependent, as Px1 protein levels were higher in female than male mice before and after MCAO (Freitas-Andrade et al., <xref ref-type="bibr" rid="B64">2017</xref>). Both Px1 knockout mice and probenecid treated mice (at 1.5 and 5 h, 250 mg/kg, i.p.), had reduced infarct volumes after MCAO compared to control, but the effect was not seen in males (Freitas-Andrade et al., <xref ref-type="bibr" rid="B64">2017</xref>). It is unclear what mechanisms are involved in producing this sex difference, but it may be related to differences in caspase-dependent cell death pathways and estrogen receptor β signaling in females (Freitas-Andrade et al., <xref ref-type="bibr" rid="B64">2017</xref>).</p>
<p>The interaction of connexin hemichannels and pannexin cell channels has been examined in astrocyte cultures exposed to hypoxia and artificial cerebral spinal fluid medium that mimics ischemic conditions in the brain (Orellana et al., <xref ref-type="bibr" rid="B142">2010</xref>). After reoxygenation, there was increased hemichannel activity, indicated by increased uptake of ethidium bromide, which peaked at 1 h after rexoygenation. This hemichannel activity was mediated by Cx43 hemichannels and not pannexin channels, as dye uptake was reduced by Cx43 hemichannel blockade or Cx43 knockout, but not pannexin blockade (Orellana et al., <xref ref-type="bibr" rid="B142">2010</xref>). This is consistent with the endothelial cell hypoxia-reperfusion study referred to above, where pannexin channel opening was reported during hypoxia, but not reperfusion (Kim and Green, <xref ref-type="bibr" rid="B101">2016</xref>). Furthermore, connexin hemichannels, but not pannexin channels, have been implicated in the inflammasome pathway in muscular dystrophy (Cea et al., <xref ref-type="bibr" rid="B24">2016</xref>), and inflammatory cytokine release normally associated with the inflammasome pathway in rodent models of Parkinson's disease (Maatouk et al., <xref ref-type="bibr" rid="B114">2018</xref>) and Alzheimer's disease (Yi et al., <xref ref-type="bibr" rid="B213">2016</xref>). Finally, pannexin channels are self-regulated, and whilst they may release ATP, they are also closed by the presence of ATP in the extracellular milieu (Qiu and Dahl, <xref ref-type="bibr" rid="B153">2009</xref>). Taken overall, it is possible that pannexin channel opening may play a role in inflammasome pathway initiation, but amplification and perpetuation in chronic disease conditions may be primarily connexin hemichannel mediated. This is likely to apply to perinatal brain injury and inflammation too, but remains to be proven.</p>
</sec>
<sec id="s6">
<title>Astrocytes and Inflammation</title>
<p>Astrocytes play an important physiological role in maintaining the homeostasis of the microenvironment in the brain. Astrocytes are the most abundant cell type and account for half of the cells in the central nervous system (Markiewicz and Lukomska, <xref ref-type="bibr" rid="B119">2006</xref>). They are electrically non-excitable cells, but have a role in propagating Ca<sup>2+</sup> waves through gap junctions between astrocytes-astrocytes and astrocytes-neurons (Nedergaard, <xref ref-type="bibr" rid="B135">1994</xref>), and extracellularly between isolated cells (Hassinger et al., <xref ref-type="bibr" rid="B84">1996</xref>). Astrocytes maintain K<sup>+</sup> ionic balance (Wallraff et al., <xref ref-type="bibr" rid="B190">2006</xref>), and have an important role in the reuptake and recycling of glutamate (Rothstein et al., <xref ref-type="bibr" rid="B160">1994</xref>). Additionally, astrocytes provide metabolic support for neurons by producing lactate, which is taken up by neurons to produce ATP (Mächler et al., <xref ref-type="bibr" rid="B115">2016</xref>).</p>
<p>Astrocytes can also contribute to the inflammatory response after perinatal brain injury. Reactive astrogliosis can occur where astrocytes undergo hypertrophy, increase expression of glial fibrillary protein and form a glial scar around a focal injury (Romero et al., <xref ref-type="bibr" rid="B158">2014</xref>). However, astrogliosis responses have varied between different experimental paradigms. GFAP expression was increased but numbers of GFAP positive cells did not change in P7 rats at 24 h after HI (Odorcyk et al., <xref ref-type="bibr" rid="B140">2017</xref>). There were increased GFAP positive cells and area fraction in preterm fetal sheep at 3 days after umbilical cord occlusion (Wassink et al., <xref ref-type="bibr" rid="B195">2017</xref>). In contrast, there were no changes in the number and area fraction of GFAP positive cells in near-term fetal sheep at 7 days after carotid artery occlusion (Davidson et al., <xref ref-type="bibr" rid="B47">2016</xref>). Moreover, there was a reduction in area fraction and the size of astrocytes in neonatal pigs at 3 days after hypoxia (Sullivan et al., <xref ref-type="bibr" rid="B172">2010</xref>).</p>
<p>Astrocytes predominantly express Cx43, with some expression of Cx26, Cx30, Cx40, and Cx45 (Nagy et al., <xref ref-type="bibr" rid="B130">1997</xref>, <xref ref-type="bibr" rid="B129">2003</xref>; Dermietzel et al., <xref ref-type="bibr" rid="B51">2000</xref>). The opening of astrocytic Cx43 hemichannels after HI may compromise the ability of astrocytes to maintain homeostasis and neuronal support. This in turn, can have detrimental effects on neuronal and oligodendrocyte survival, the propagation of seizures and secondary energy failure (Davidson et al., <xref ref-type="bibr" rid="B41">2013a</xref>). Additionally, astrocytes cultures subjected to OGD/reperfusion increased ATP release through Cx43 hemichannels. Further, treating OGD/reperfusion microglial cultures with ATP or medium from astrocytes subjected to OGD/reperfusion induced microglial activation (Yin et al., <xref ref-type="bibr" rid="B215">2018b</xref>). The potential mechanisms of microglial activation through ATP signaling is discussed further below.</p>
</sec>
<sec id="s7">
<title>Microglia and Inflammation</title>
<p>Microglia are the innate immune cells of the brain; having an important role in immune surveillance under normal conditions (Nimmerjahn et al., <xref ref-type="bibr" rid="B137">2005</xref>). Aside from their immune function, they are important for apoptosis and pruning of excessive neurons and synapses, and the phagocytosis of debris during brain development (Baburamani et al., <xref ref-type="bibr" rid="B5">2014</xref>). After brain injury, however, microglia undergo proliferation and activation during the inflammatory response (Baburamani et al., <xref ref-type="bibr" rid="B5">2014</xref>). Resting microglia commonly have ramified morphology and become amoeboid when activated. However, during development, microglia migrate in the brain in amoeboid form and change into a ramified morphology (Pierre et al., <xref ref-type="bibr" rid="B151">2017</xref>).</p>
<p>Activated microglia have various roles, where the classically activated, or M1-like polarization facilitates the progression of inflammation and the alternatively activated, or M2-like polarization is involved in the resolution of inflammation (Bonestroo et al., <xref ref-type="bibr" rid="B19">2013</xref>; Jaworska et al., <xref ref-type="bibr" rid="B92">2017</xref>). The M1-like microglia express cluster of differentiation (CD)86, CD16, CD32, produce reactive oxygen species and nitric oxide synthase, proteases, a range of interleukins and inflammatory cytokines, such as IL-1β, IL-6, and TNF-α (Czeh et al., <xref ref-type="bibr" rid="B37">2011</xref>; Barakat and Redzic, <xref ref-type="bibr" rid="B9">2015</xref>; Fumagalli et al., <xref ref-type="bibr" rid="B67">2015</xref>). The M2-like polarization express CD206 and arginase 1 and produce anti-inflammatory IL-10 and growth factors, favoring repair (Czeh et al., <xref ref-type="bibr" rid="B37">2011</xref>; Barakat and Redzic, <xref ref-type="bibr" rid="B9">2015</xref>; Fumagalli et al., <xref ref-type="bibr" rid="B67">2015</xref>). However, the view that there is a clear polarization of the microglia phenotypes has been challenged in recent years, and currently it is hypothesized that microglial polarization is a continuum with M1 on one end, and M2 on the other (Cherry et al., <xref ref-type="bibr" rid="B29">2014</xref>; Hellström et al., <xref ref-type="bibr" rid="B87">2016</xref>).</p>
<p>In P7 rats, there was a marked increase in CD45/CD11b positive cells in injured areas at 24 h after transient MCAO. These cells were predominantly microglia and not infiltrated blood monocytes (Denker et al., <xref ref-type="bibr" rid="B50">2007</xref>). Supporting this, microglia/macrophage counts were significantly elevated in the hippocampus from 1 day after common carotid artery ligation and hypoxia in P9 mice (human term brain maturation equivalent) (Ferrazzano et al., <xref ref-type="bibr" rid="B58">2013</xref>). There may be a biphasic response of microglial upregulation, with an initial increase in microglial number in the hippocampus at 2 days, followed by a delayed increased in the striatum and cortex at 9 days, after common carotid artery ligation and hypoxia in P9 mice (Cikla et al., <xref ref-type="bibr" rid="B31">2016</xref>). Similarly, classically activated CD11b/CD86 positive microglia from whole brain homogenates were upregulated at 24 h, followed by a secondary peak at 1 week, which was resolved to control levels by 2 weeks after HI (Rice-Vannucci model) in P10 mice (Winerdal et al., <xref ref-type="bibr" rid="B204">2012</xref>). However, the alternative microglial activation markers were not assessed in that study. Significantly elevated counts of ionized calcium-binding adapter molecule 1 (Iba1) positive microglia in the intragyral white matter of the first and second parasagittal gyrus, and the periventricular white matter were present after 1 week of recovery from global cerebral ischemia in near-term fetal sheep (Davidson et al., <xref ref-type="bibr" rid="B46">2015c</xref>, <xref ref-type="bibr" rid="B47">2016</xref>). Moreover, Iba1 positive microglial number was still elevated in the same white matter regions as above at 21 days after severe HI induced by acute umbilical cord occlusion in preterm fetal sheep (van den Heuij et al., <xref ref-type="bibr" rid="B185">2019</xref>). This longer term recovery highlights the chronic nature of inflammation after perinatal HI insults.</p>
<p>The functions of activated microglia appear to change over time after HI. The activation characterization of microglia and infiltrated macrophages has been assessed in P9 mice after common carotid artery occlusion followed by hypoxia (Hellström et al., <xref ref-type="bibr" rid="B87">2016</xref>). There was an increase in mRNA levels of both pro and anti-inflammatory genes at 24 h after the insult. Furthermore, there was a significant increase in classically activated CD86 positive microglia. In contrast, although absolute numbers of alternatively activated CD206 positive microglia increased, their relative proportion was reduced. Surprisingly, there was a population of microglia which did not express CD86 or CD206, highlighting the complexity of microglia activation polarization (Hellström et al., <xref ref-type="bibr" rid="B87">2016</xref>). The early rise of pro-inflammatory markers is supported by an increase of IL-1β and TNF-α mRNA expression between 1 and 24 h after HI in P7 rats (Rice-Vannucci model) (Bona et al., <xref ref-type="bibr" rid="B18">1999</xref>). In another study, using the same paradigm to induce HI in P7 rats, both pro-inflammatory (IL-1β, TNF-α) and anti-inflammatory (IL-10) mRNA expression increased at 3 h after the insult. At 24 h, TNF-α expression was still elevated, but was lower than at 3 h. In addition, anti-inflammatory cytokine TGF-β expression also increased at 24 h along with an increase of CD206 and Iba1 positive microglia (Bonestroo et al., <xref ref-type="bibr" rid="B19">2013</xref>). However, in P7 rats, the majority of CD86 positive microglia were co-localized with IL-1β and only a small number were co-localized with arginase-1, at 6 days after carotid artery ligation and hypoxia (Jaworska et al., <xref ref-type="bibr" rid="B92">2017</xref>). Although some studies indicate a trend toward resolution of inflammation over time, microglia remain upregulated even 3 weeks after HI in preterm fetal sheep (van den Heuij et al., <xref ref-type="bibr" rid="B185">2019</xref>), and so further experimental studies are needed to determine the function of microglia at these later time points.</p>
<p>The increase in inflammatory cytokine release highlighted in the studies above is consistent with NLRP3 inflammasome activation (Shao et al., <xref ref-type="bibr" rid="B165">2018</xref>). Both astrocytes and microglia are known to play key roles in the inflammasome pathway (for review see Song et al., <xref ref-type="bibr" rid="B168">2017</xref>).</p>
</sec>
<sec id="s8">
<title>ATP Release From Membrane Channels</title>
<p>Both connexin hemichannels and pannexin channels can contribute to ATP release into the extracellular space (Kang et al., <xref ref-type="bibr" rid="B97">2008</xref>; Chekeni et al., <xref ref-type="bibr" rid="B26">2010</xref>; Orellana et al., <xref ref-type="bibr" rid="B141">2011</xref>; Bennett et al., <xref ref-type="bibr" rid="B15">2012</xref>), although, as discussed above, pannexin channels may also be regulated (closed) by extracellular ATP (Qiu and Dahl, <xref ref-type="bibr" rid="B153">2009</xref>). ATP is a high energy molecule, essential for driving many cellular processes in the body. It also has a crucial neurotransmitter and neuromodulatory role in the brain (Melani et al., <xref ref-type="bibr" rid="B126">2005</xref>; Pedata et al., <xref ref-type="bibr" rid="B148">2016</xref>). ATP can be co-released with other neurotransmitters or function as an extracellular signaling molecule on its own (Burnstock, <xref ref-type="bibr" rid="B22">2009</xref>; Suurväli et al., <xref ref-type="bibr" rid="B174">2017</xref>). However, under pathological conditions, it may have injurious effects acting as a DAMP (Melani et al., <xref ref-type="bibr" rid="B126">2005</xref>; Pedata et al., <xref ref-type="bibr" rid="B148">2016</xref>) but more crucially as an inflammasome signal 2 activator. Extracellular ATP can activate purinergic receptors, which can perpetuate inflammasome activity in a number of brain cell types, including microglia (Bours et al., <xref ref-type="bibr" rid="B20">2011</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Schematic diagram of the potential involvement of connexin 43 hemichannels and pannexin 1 channels and purinergic receptors P2X4 and P2X7 in the activation of microglia and NLRP3 inflammasome. Cx43 hemichannels and Px1 channels may open after exposure to HI or infection/inflammation. The opening of these channels leads to the release of ATP into the extracellular space. Extracellular ATP can activate purinergic receptors P2X4R and P2X7R. The activation of P2X4R and P2X7R can lead to the activation of microglia. Signal 1 of NLRP3 inflammasome activation is provided by PAMPs or DAMPs, which leads to the upregulation of NLRP3, pro-IL-1β, and pro-IL-18. Signal 2 is mediated by ATP activation of P2X7R and can lead to the assembly of NLRP3, ASC, and pro-caspase 1, forming the NLRP3 inflammasome. Pro-caspase 1 is activated into caspase 1, which cleaves pro-IL-1β and pro-IL-18 into their mature forms. Mature IL-1β and IL-18 is secreted.</p>
</caption>
<graphic xlink:href="fphys-10-00141-g0002"></graphic>
</fig>
<p>The bulk of ATP production occurs in mitochondria through oxidative metabolism, but a small amount is produced through anaerobic glycolysis. The disruption of oxygen and glucose delivery during HI affects oxidative metabolism, attenuating the production of ATP (Bainbridge et al., <xref ref-type="bibr" rid="B7">2014</xref>; Wassink et al., <xref ref-type="bibr" rid="B197">2014</xref>). ATP is critical for the function of Na<sup>+</sup>/K<sup>+</sup>-ATPase, which maintain ionic gradients. When ATP is depleted, the failure to maintain cellular ionic homeostasis causes cytotoxic edema, which is indicated by a rise in cortical impedance starting soon after the onset of ischemia in near-term fetal sheep (Williams et al., <xref ref-type="bibr" rid="B203">1993</xref>; Davidson et al., <xref ref-type="bibr" rid="B39">2018b</xref>). We have previously shown that during profound asphyxia in near-term fetal sheep, there was a rapid increase in oxidized cytochrome oxidase at 2–6 min from the start of asphyxia (Drury et al., <xref ref-type="bibr" rid="B53">2012</xref>). The increase in oxidized cytochrome oxidase indicate that there was a decreased availability of reducing equivalents in the mitochondrial electron transport chain, impairing ATP production. Additionally, a phosphorus magnetic resonance spectroscopy study showed that cerebral phosphocreatine and total nucleotide triphosphate decreased, whereas inorganic phosphate increased during HI in neonatal piglets (Bainbridge et al., <xref ref-type="bibr" rid="B7">2014</xref>). During secondary energy failure at 24 and 48 h after HI in neonatal piglets, the cerebral phosphocreatine/inorganic phosphate and nucleotide triphosphate/exchangeable phosphate pool also decreased (Lorek et al., <xref ref-type="bibr" rid="B113">1994</xref>).</p>
<p>Paradoxically, at a time when ATP production is impaired, there is augmented ATP release into the extracellular space after permanent MCAO in the adult rat brain (Melani et al., <xref ref-type="bibr" rid="B126">2005</xref>, <xref ref-type="bibr" rid="B125">2012</xref>). Microdialysis samples collected from the striatum showed that ATP concentrations were an average of 30 nmol/L before ischemia, which increased to an average of 50 nmol/L after permanent MCAO (Melani et al., <xref ref-type="bibr" rid="B125">2012</xref>). When an ecto-ATPase inhibitor—hexapotassium dihydrogen monotitanoundecatungstocobaltate (II) tridecahydrate (PV4, 100 μmol/L) was used, the extracellular ATP concentrations were between 320 and 450 nmol/L (Melani et al., <xref ref-type="bibr" rid="B125">2012</xref>). This is within the range of what was detected in hippocampal slices during reoxygenation after OGD (700 nmol/L), using a biosensor measured in real time (Frenguelli et al., <xref ref-type="bibr" rid="B65">2007</xref>). However, extracellular ATP release has not been examined after HI in the developing brain.</p>
<p>The increase in extracellular ATP can lead to a subsequent increase in adenosine, as ATP is catabolized into adenosine, through the ATP → ADP → AMP → adenosine pathway, mediated by ecto-nucleotidase enzymes (Pedata et al., <xref ref-type="bibr" rid="B148">2016</xref>). Adenosine concentrations increased by 90% during a 1 h period of fetal hypoxia induced by reduction of maternal fraction of inspired oxygen, compared to levels during normoxia in 0.8 gestation fetal sheep (Koos et al., <xref ref-type="bibr" rid="B102">1997</xref>). The rise in adenosine concentrations was attributed to the degradation of AMP, as blocking the degradation of AMP to adenosine with adenosine 5′-(α,β-methylene) diphosphate (AOPCP), an ecto-5′-nucleotidase inhibitor, attenuated the hypoxia-induced rise in adenosine (Koos et al., <xref ref-type="bibr" rid="B102">1997</xref>). In support, in the first hour after permanent MCAO in the adult rat brain, extracellular adenosine was mainly derived from ATP hydrolysis (Melani et al., <xref ref-type="bibr" rid="B125">2012</xref>). This is in contrast to physiological conditions, when adenosine can be directly released from intracellular stores (Melani et al., <xref ref-type="bibr" rid="B125">2012</xref>). Adenosine is very important to the initial metabolic suppression that occurs at the beginning of an HI insult (Hunter et al., <xref ref-type="bibr" rid="B89">2003</xref>). Blocking this response with the adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (2.5 mg/mL) in near-term fetal sheep before and during profound asphyxia, was associated with increased neuronal loss compared to the vehicle group (Hunter et al., <xref ref-type="bibr" rid="B89">2003</xref>). Further studies are needed to examine the interaction of ATP and adenosine <italic>in vivo</italic>, in the developing brain after HI, and to investigate inflammasome complex assembly under those conditions. In parallel, it is necessary to consider the purinergic receptors themselves (see section Purinergic Receptors).</p>
</sec>
<sec id="s9">
<title>Purinergic Receptors</title>
<p>Purinergic P1 and P2 receptors are activated by adenosine and ATP, respectively. Within the group of P2 receptors, there are P2X receptors, which are ionotropic and P2Y, which are metabotropic (Pedata et al., <xref ref-type="bibr" rid="B148">2016</xref>). In this review, we will focus on the P2X receptors, which form trimeric cationic channels in the cell membrane (Habermacher et al., <xref ref-type="bibr" rid="B82">2016</xref>). Of the seven P2X subtypes (P2X1-7), P2X4 receptor (P2X4R), and P2X7 receptor (P2X7R) have been more widely studied in the brain (Pedata et al., <xref ref-type="bibr" rid="B148">2016</xref>). These channels open in response to ATP binding and are permeable to Na<sup>+</sup>, K<sup>+</sup>, and especially Ca<sup>2+</sup> (Hattori and Gouaux, <xref ref-type="bibr" rid="B85">2012</xref>). The activation of purinergic receptors can lead to the opening of more connexin hemichannels (and at least potentially pannexin channels), triggering further release of ATP in a process known as “ATP-induced ATP release” in a positive feedback loop (Stout et al., <xref ref-type="bibr" rid="B170">2002</xref>; Baroja-Mazo et al., <xref ref-type="bibr" rid="B10">2013</xref>).</p>
<sec>
<title>P2X4 Receptor</title>
<p>P2X4R is one of the most sensitive P2X receptors, as it binds ATP in the nanomolar range, whereas P2X7R binds at a micromolar range (Suurväli et al., <xref ref-type="bibr" rid="B174">2017</xref>). It also has the highest permeability to Ca<sup>2+</sup>, and is the most abundantly expressed P2X subtype in the brain (Egan and Khakh, <xref ref-type="bibr" rid="B55">2004</xref>; Cheng et al., <xref ref-type="bibr" rid="B28">2014</xref>), found on neurons and glial cells, in various brain regions (Bo et al., <xref ref-type="bibr" rid="B16">2003</xref>; Stokes et al., <xref ref-type="bibr" rid="B169">2017</xref>; Suurväli et al., <xref ref-type="bibr" rid="B174">2017</xref>). Under physiological conditions, P2X4R may have an important role in neurotransmission pathways (Suurväli et al., <xref ref-type="bibr" rid="B174">2017</xref>). P2X4 knockout mice show deficits in sensorimotor tasks and social interactions, which was associated with altered subunit expression of glutamate and gamma-aminobutyric acid (GABA) receptors (Wyatt et al., <xref ref-type="bibr" rid="B206">2013</xref>). As P2X4R is expressed abundantly in cells of myeloid origin, such as microglia and monocytes, they may play important roles in pro-inflammatory cytokine release following injury (Cavaliere et al., <xref ref-type="bibr" rid="B23">2003</xref>).</p>
<p>P2X4R has been targeted for neuroprotection after HI. Global P2X4R knockout mice have a reduction in infarct volume and IL-1β and TNF-α release after MCAO compared to wild type mice (Verma et al., <xref ref-type="bibr" rid="B187">2017</xref>). However, when P2X4R was knocked out in myeloid cells only, the neuroprotective effect was only seen in females. The role of P2X4R is complex, as the P2X4R knockout was associated with increased depressive-like behavior compared to wild type mice measured at 30 days after MCAO (Verma et al., <xref ref-type="bibr" rid="B187">2017</xref>). In addition, P2X4R on vascular endothelial cells was involved in neuroprotection via ischemic preconditioning after MCAO in adult mice, as the inhibition of P2X4R abolished this effect (Ozaki et al., <xref ref-type="bibr" rid="B144">2016</xref>).</p>
</sec>
<sec>
<title>P2X4 Receptor and Activation of Microglia</title>
<p>Microglia and peripheral monocytes have been shown to express P2X4R, and electrical currents can be induced by ATP activation of P2X4R (Wang et al., <xref ref-type="bibr" rid="B193">2004</xref>; Cheng et al., <xref ref-type="bibr" rid="B28">2014</xref>). The expression of P2X4R is upregulated in organotypic hippocampal culture at 24 h after OGD (Cavaliere et al., <xref ref-type="bibr" rid="B23">2003</xref>) In P0 rats, P2X4R protein expression increased from 4 h after hypoxia until 14 days (Li et al., <xref ref-type="bibr" rid="B110">2011</xref>). However, in P3 rats, there was a significant increase in P2X4R protein expression only at 5 days after common carotid artery occlusion and hypoxia (Wixey et al., <xref ref-type="bibr" rid="B205">2009</xref>). In both neonatal rat studies, P2X4R expression was predominantly colocalized with microglia (Wixey et al., <xref ref-type="bibr" rid="B205">2009</xref>; Li et al., <xref ref-type="bibr" rid="B110">2011</xref>). Although the increase in P2X4R at 5 days was not temporally correlated with the early increase in Iba1 protein expression seen at 2 days after HI, it correlated with the delayed increase in Iba1 protein expression from 6 days after HI. It was postulated that these P2X4R positive microglia may be a distinct population of microglia involved in neuroinflammation (Wixey et al., <xref ref-type="bibr" rid="B205">2009</xref>). Furthermore, P2X4R blockade with trinitrophenyl (TNP)-ATP (20 μM) prevented the change of primary microglial cells to a more rounded morphology after hypoxia, and attenuated the increased IL-1β and TNF-α protein expression (Li et al., <xref ref-type="bibr" rid="B110">2011</xref>).</p>
</sec>
<sec>
<title>P2X7 Receptor</title>
<p>Although, P2X7R has a lower affinity of 0.1–1 mM for ATP, when compared to P2X4R, the increased extracellular ATP levels after ischemia may be sufficient to activate it (Surprenant and North, <xref ref-type="bibr" rid="B173">2009</xref>; Melani et al., <xref ref-type="bibr" rid="B125">2012</xref>). The deleterious roles of the P2X7R include increasing intracellular Ca<sup>2+</sup> concentrations, glutamate release and inflammasome activation (Di Virgilio, <xref ref-type="bibr" rid="B52">2007</xref>; Matute et al., <xref ref-type="bibr" rid="B122">2007</xref>; Rossi and Volterra, <xref ref-type="bibr" rid="B159">2009</xref>; Ye et al., <xref ref-type="bibr" rid="B211">2017</xref>). Additionally, prolonged ATP activation of P2X7R can transform the cationic channel into a large membrane pore, permeable to molecules 900 Da in size (Yan et al., <xref ref-type="bibr" rid="B209">2010</xref>).</p>
<p>Animal studies have shown that P2X7R is upregulated after ischemia in the immature and adult brain. In a fetal rat model of intrauterine asphyxia, P2X7R expression in the hippocampus was upregulated 3-fold immediately after asphyxia, but returned to control levels at 60 min (Frizzo et al., <xref ref-type="bibr" rid="B66">2010</xref>). In adult rats, however, cortical P2X7R expression was increased 5-fold compared to controls at 4 days after permanent MCAO (Franke et al., <xref ref-type="bibr" rid="B62">2004</xref>). Whereas, in adult mice subjected to photothrombotic cerebral ischemia, cortical P2X7R expression was upregulated from 1 day post-ischemia until 5 days (Ye et al., <xref ref-type="bibr" rid="B211">2017</xref>). In cortical neuronal culture, there was a significant upregulation of P2X7R after exposure to OGD (Ye et al., <xref ref-type="bibr" rid="B211">2017</xref>). P2X7R expression was increased in the CA1 region of the hippocampus from 6 h and maintained until 7 days after global cerebral ischemia in adult rats (Yu et al., <xref ref-type="bibr" rid="B217">2013</xref>). The differences in the timing of P2X7R upregulation could be due age, species, brain region and type of insult.</p>
<p>Blocking P2X7R has been shown to be beneficial for ischemic brain injury <italic>in vitro</italic> and in adult animals. In neuronal culture, Brilliant Blue G—a P2X7R blocker (50 nM or 5 μM), applied during OGD, reduced cell death measured at 24 h after OGD (Arbeloa et al., <xref ref-type="bibr" rid="B2">2012</xref>). This was replicated <italic>in vivo</italic>; Brilliant Blue G (30 mg/kg, i.p.) administered at 30 min during a 90 min MCAO and continued daily in adult rats reduced infarct volume and neuronal loss when measured at 3 days after the insult (Arbeloa et al., <xref ref-type="bibr" rid="B2">2012</xref>). In support, Brilliant Blue G treatment (50 mg/kg, i.v.) administered daily, for 3 days, starting immediately after occluding bilateral common carotid and vertebral arteries in adult rats, partially attenuated CA1 neuronal loss in the hippocampus at 7 days after injury (Yu et al., <xref ref-type="bibr" rid="B217">2013</xref>). Although Brilliant Blue G has higher affinity for P2X7R, it can also bind to other P2X receptors at higher concentrations (Chu et al., <xref ref-type="bibr" rid="B30">2012</xref>). However, the administration of a more selective P2X7R antagonist—A-438079 (3 μg, i.c.v.), prior to transient common carotid artery occlusion in adult rats, had similar neuroprotective effects to Brilliant Blue G (10 μg, i.c.v.) and Oxidized ATP (1 μg, i.c.v.), in terms of neuronal survival and motor performance (Chu et al., <xref ref-type="bibr" rid="B30">2012</xref>). Additionally, in an adult rat model of intracerebral hemorrhage, silencing the P2X7R gene reduced NLRP3 inflammasome activation and release of IL-1β and IL-18 at 24 h after the insult (Feng et al., <xref ref-type="bibr" rid="B57">2015</xref>). It is difficult to disentangle the timing of when P2X7R is involved in injury, as most of these studies above started blocking P2X7R either during or immediately after ischemia.</p>
<p>Several studies have shown that connexin hemichannels and pannexin channels are involved in purinergic signaling. For example, IL-1β release induced by P2X7R activation was associated with Px1 channels in macrophages (Pelegrin and Surprenant, <xref ref-type="bibr" rid="B149">2006</xref>). When a Px1 blocker—mefloquine (1 mg/kg, i.p.) was co-administered with Brilliant Blue G (30 mg/kg twice per day, i.p.) to block P2X7R, starting at 30 min during 60 min of MCAO, there was no additive benefit when compared to administering either drug alone in adult mice after MCAO (Cisneros-Mejorado et al., <xref ref-type="bibr" rid="B32">2015a</xref>). However, as stated earlier, mefloquine can also target connexin hemichannels (Cruikshank et al., <xref ref-type="bibr" rid="B36">2004</xref>). A potential mechanism of injury may be ATP release, as both the prevention of ATP release, or inhibition of P2X7R may have beneficial effects (Cisneros-Mejorado et al., <xref ref-type="bibr" rid="B33">2015b</xref>). For example, targeting Cx43 using Peptide5 at 0 h (10 mg/kg), 2 h (5 mg/kg), and 4 h (2.5 mg/kg, i.p.), after spinal cord injury in rats was associated with a reduction is tissue damage and improved functional recovery (Mao et al., <xref ref-type="bibr" rid="B118">2017</xref>). Similarly, the administration of Brilliant Blue G to inhibit P2X7R (10 or 50 mg/kg daily for 3 days) starting 10–15 min after spinal cord injury in rats, reduced tissue damage and improved motor performance (Peng et al., <xref ref-type="bibr" rid="B150">2009</xref>).</p>
</sec>
<sec>
<title>P2X7 Receptor and Activation of Microglia</title>
<p>In adult rats after MCAO, the expression of P2X7R was colocalized with microglia at 1 and 4 days, neurons at 4 and 7 days, and astrocytes at 4 days after the insult (Franke et al., <xref ref-type="bibr" rid="B62">2004</xref>). <italic>De novo</italic> expression of P2X7R was observed on activated microglia at 24 h after MCAO in adult rats, with no expression seen in control animals (Melani et al., <xref ref-type="bibr" rid="B124">2006</xref>). It has been debated as to whether the overexpression of P2X7R drives the activation of microglia, or whether the overexpression of P2X7R is a result of microglial activation (Bai and Li, <xref ref-type="bibr" rid="B6">2013</xref>). In support of the role of P2X7R in microglia activation, the overexpression of P2X7R by transfection of microglia in culture resulted in activation and proliferation of microglia (Monif et al., <xref ref-type="bibr" rid="B127">2009</xref>). Additionally, P2X7R knockout mice showed significantly attenuated microglial activation at 72 h following MCAO compared to wild type mice (Kaiser et al., <xref ref-type="bibr" rid="B96">2016</xref>). In the developing brain, both P2X7R and P2X4R were constitutively expressed in microglia in P3 rats, but P2X4R immunofluorescence was more intense than P2X7R. However, only the changes in P2X4R expression was examined after exposure to hypoxia in P0 rats (Li et al., <xref ref-type="bibr" rid="B110">2011</xref>).</p>
</sec>
</sec>
<sec id="s10">
<title>Activation of the Inflammasome</title>
<p>The family of PRRs include Toll-like receptors (TRLs), NOD-like receptors (NLRs), and retinoic acid-inducible gene-I-like receptors (RLRs) which recognize PAMPs or DAMPs (Hagberg et al., <xref ref-type="bibr" rid="B83">2015</xref>; Mallard et al., <xref ref-type="bibr" rid="B117">2018</xref>). There is growing interest in the role of NLRs in inflammatory diseases, but relatively little is known about their role in perinatal brain injury. Inflammasomes are a multimeric complex of proteins which oligomerize after sensing PAMP or DAMP signals (Jo et al., <xref ref-type="bibr" rid="B94">2016</xref>). Typically, NLR inflammsomes are formed by the assembly of the NLR family protein, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and pro-caspase 1. The 22 members of the NLR family are distinguished by their N-terminal effector domains, and grouped into NLRA, NLRB, NLRC and NLRP (Ting et al., <xref ref-type="bibr" rid="B181">2008</xref>). One of the better characterized inflammasomes in the NLR family is the NOD-like receptor protein-3 (NLRP3) inflammasome. The activation of the NLRP3 inflammasome leads to the activation of caspase 1, the cleavage and release of mature IL-1β and IL-18 and subsequent release of other cytokines (Jo et al., <xref ref-type="bibr" rid="B94">2016</xref>; Mugisho et al., <xref ref-type="bibr" rid="B128">2018</xref>).</p>
<p>There are two steps to NLRP3 inflammasome activation. Signal 1 is a priming step, induced by PAMPS, such as microbial toxins and surface proteins, TLR ligands and viral RNA (Martinon et al., <xref ref-type="bibr" rid="B121">2009</xref>; Jun et al., <xref ref-type="bibr" rid="B95">2012</xref>; Chakrabarti et al., <xref ref-type="bibr" rid="B25">2015</xref>) or DAMPs, such as amyloid-β, hyaluronan, monosodium urate, calcium pyrophosphate dehydrate and extracellular ATP (Martinon et al., <xref ref-type="bibr" rid="B121">2009</xref>; Gong et al., <xref ref-type="bibr" rid="B77">2018</xref>). Endogenous inflammatory cytokines including TNF-α and IL-1β can also act as priming signals (Franchi et al., <xref ref-type="bibr" rid="B61">2009</xref>; He et al., <xref ref-type="bibr" rid="B86">2016</xref>; Gong et al., <xref ref-type="bibr" rid="B77">2018</xref>). The priming signal leads to the upregulation of NLRP3 and pro-IL-1β and pro-IL-18 expression through the nuclear factor kappa-light-chain-(NF-κB) translocation to the nucleus to trigger their transcription (He et al., <xref ref-type="bibr" rid="B86">2016</xref>). Signal 2 of the NLRP3 inflammasome is the activation signal. This leads to assembly of the inflammasome complex. A clear model for activation remains unclear; much of the literature suggests that many of the same molecules involved in priming may have a secondary role in activation (Shao et al., <xref ref-type="bibr" rid="B165">2018</xref>). That seems unlikely. Thus, is remains a significant question to define which molecular mechanism(s) trigger activation of the NLRP3 inflammasome (He et al., <xref ref-type="bibr" rid="B86">2016</xref>; Jo et al., <xref ref-type="bibr" rid="B94">2016</xref>). More recently, the list of potential activator signals has been narrowed down. Key players are now suggested to include: ATP, calcium signaling, and reactive oxygen species (He et al., <xref ref-type="bibr" rid="B86">2016</xref>; Jo et al., <xref ref-type="bibr" rid="B94">2016</xref>; Groslambert and Py, <xref ref-type="bibr" rid="B79">2018</xref>). Mitochondrial dysfunction, lysosomal rupture and K<sup>+</sup> efflux are also reported to be activators (He et al., <xref ref-type="bibr" rid="B86">2016</xref>; Gao et al., <xref ref-type="bibr" rid="B71">2017</xref>), although it is unclear to what extent some of these may be effects of inflammation rather than initiators <italic>per se</italic>.</p>
<p>Potassium efflux can be mediated through the opening of endogenous ion channels or through bacterial pore forming toxins (Gao et al., <xref ref-type="bibr" rid="B71">2017</xref>). Purinergic receptors have been associated with the efflux of K<sup>+</sup> (Yan et al., <xref ref-type="bibr" rid="B210">2008</xref>) as have connexin hemichannels (Schalper et al., <xref ref-type="bibr" rid="B163">2010</xref>; Leybaert et al., <xref ref-type="bibr" rid="B109">2017</xref>). It is unclear how the reduction in intracellular K<sup>+</sup> leads to the activation of the inflammasome although studies have shown that it is a necessary step for the kinase Never In Mitosis A-Related Kinase 7 to bind to NLRP3, required for the assembly of the inflammasome (He et al., <xref ref-type="bibr" rid="B86">2016</xref>; Shi et al., <xref ref-type="bibr" rid="B167">2016</xref>). Additionally, K<sup>+</sup> efflux can lead to the disruption of mitochondrial function and production of mitochondrial reactive oxygen species (Tang et al., <xref ref-type="bibr" rid="B176">2017</xref>). It is also of note that potassium efflux is induced by ATP suggesting that ATP release may therefore be the primary or upstream activator not only for potassium efflux, but also mitochondrial dysfunction and reactive oxygen species. Our work has shown that reducing ATP release on its own alone (by blocking connexin hemichannels alone) is sufficient to shut down inflammasome complex assembly, while the addition of exogenous ATP sufficient to reestablish assembly (Mugisho et al., <xref ref-type="bibr" rid="B128">2018</xref>), consistent with the evidence that purinergic receptors play a key role, as outlined above and in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<sec>
<title>Inflammasome Activation in Brain Injury</title>
<p>A large body of evidence in the adult brain shows that inflammation is a least in part mediated by the NLRP3 inflammasome in animal models of stroke, traumatic brain injury and subarachnoid hemorrhage with upregulation of mRNA or protein expression of NLRP3, ASC, caspase-1 and associated inflammatory cytokines, such as TNF-α, IL-18 and IL-6 (Gao et al., <xref ref-type="bibr" rid="B71">2017</xref>; Ye et al., <xref ref-type="bibr" rid="B211">2017</xref>; Ismael et al., <xref ref-type="bibr" rid="B91">2018</xref>; Lee et al., <xref ref-type="bibr" rid="B108">2018</xref>; Wang et al., <xref ref-type="bibr" rid="B191">2018</xref>; Xu et al., <xref ref-type="bibr" rid="B208">2018</xref>; Yin et al., <xref ref-type="bibr" rid="B214">2018a</xref>). Additionally, clinical data show that children with severe traumatic brain injury (open/closed head injury not specified) had elevated levels of NLRP3 in cerebrospinal fluid collected between 0 to ~72 h after the injury (Wallisch et al., <xref ref-type="bibr" rid="B189">2017</xref>). NLRP3 and IL-1β mRNA expression was increased in the hippocampus, striatum and the thalamus at 24 h after common carotid artery ligation followed by hypoxia in P9 neonatal mice (Ystgaard et al., <xref ref-type="bibr" rid="B216">2015</xref>). Supporting this, NLRP3 immunofluorescence increased at 24 h after common carotid artery ligation and hypoxia in P7 rats, which was predominantly colocalized with microglia (Chen et al., <xref ref-type="bibr" rid="B27">2018</xref>). Additionally, there was an increase in IL-1β, caspase 1 and NLRP3 protein expression (Chen et al., <xref ref-type="bibr" rid="B27">2018</xref>).</p>
<p>Targeting the NLRP3 inflammasome has neuroprotective effects in ischemic brain injury either through selective inhibition of NLRP3, or through anti-inflammatory drugs which affect the NLRP3 pathway (Ye et al., <xref ref-type="bibr" rid="B211">2017</xref>; Chen et al., <xref ref-type="bibr" rid="B27">2018</xref>; Ismael et al., <xref ref-type="bibr" rid="B91">2018</xref>). The selective inhibition of NLRP3 using MCC950 (50 mg/kg, i.p. <italic>in vivo</italic> and 1 μM <italic>in vitro</italic>) reduced neuronal apoptosis when delivered after photothrombotic cerebral ischemia in adult mice, and before OGD in neuronal cultures (Ye et al., <xref ref-type="bibr" rid="B211">2017</xref>). In support, MCC950 (50 mg/kg, i.p.) administration at 1 and 3 h was associated with a reduction in infarction size and cerebral edema, and improved neurological deficit scores, after MCAO in adult mice. These findings were in turn associated with a decrease in protein levels of NLRP3, caspase 1 and ASC at 24 h after the insult (Ismael et al., <xref ref-type="bibr" rid="B91">2018</xref>). Ginkgolide B—a component of Ginkgo biloba extracts (5–10 mg/kg, i.p.), which has anti-inflammatory effects, was administered to P7 rats 30 min prior to common carotid artery ligation and hypoxia and was associated with the attenuation of the increased expression of NLRP3, caspase 1 and IL-1β at 24 h after injury. These changes were accompanied by reduced infarct size and cerebral edema measured at 72 h (Chen et al., <xref ref-type="bibr" rid="B27">2018</xref>). In contrast, NLRP3 knockout was not associated with neuroprotection in P9 mice, as infarction volume was not significantly different compared to wild type mice at 24 h after common carotid artery ligation and hypoxia (Ystgaard et al., <xref ref-type="bibr" rid="B216">2015</xref>) and in some cases other NLRs or other pathways may be implicated.</p>
</sec>
<sec>
<title>Inflammasome Activation in Perinatal Infection/Inflammation</title>
<p>The studies discussed in this review predominantly focused on the role of connexin hemichannels and pannexin channels and purinergic receptors in experimental models of HI. Given that HI and infection/inflammation both lead to neuroinflammation, it is possible that both may be perpetuated through inflammasome pathway activation. In this section, we discuss the evidence for inflammasome activation in infection/inflammation in clinical and experimental studies.</p>
<p>Inflammasome activation, at least in adults, is an important inflammatory response to combat infection. For example, adult mice deficient in NLRP3, ASC, or caspase 1 have reduced survival rates compared to wild type mice after Group B Streptococcus infection (Costa et al., <xref ref-type="bibr" rid="B35">2012</xref>). Group B Streptococcus is a Gram-positive bacterium that is common cause of life-threatening sepsis and meningitis in neonates and pregnant women (Henneke and Berner, <xref ref-type="bibr" rid="B88">2006</xref>). Preterm and very-low-birthweight neonates are susceptible to neonatal sepsis likely due to increased risk of exposure to microbes (for example via mechanical ventilation, intravenous catheters and parenteral feeding). Secondly, they may have deficits in their innate and adaptive immune responses leading to insufficient inflammatory mediators (Wynn and Wong, <xref ref-type="bibr" rid="B207">2010</xref>; Strunk et al., <xref ref-type="bibr" rid="B171">2011</xref>). In view of the latter, a study of 21 preterm infants born 24–32 weeks showed that preterm umbilical cord blood monocytes, had a reduction in IL-1β secretion and an induction of NLRP3 expression, compared to term infants and adult peripheral monocytes after ATP/LPS stimulation (Sharma et al., <xref ref-type="bibr" rid="B166">2015</xref>). However, IL-1β secretion from preterm peripheral blood monocytes (24–29 weeks of gestation) collected at an average of 15 post-natal days was comparable to adult monocytes, suggesting that the impairment in IL-1β secretion is restored shortly after birth (Sharma et al., <xref ref-type="bibr" rid="B166">2015</xref>). A study of 72 neonates showed that IL-1β secretion from peripheral blood mononuclear cells did not differ between extremely preterm (born &lt;28 weeks) and very preterm infants (28–32 weeks) on the fifth day of life. However, the peripheral blood mononuclear cells (collected within 24 h of late onset sepsis) from the extremely preterm group secreted higher levels of IL-1β, than the very preterm neonates (Zasada et al., <xref ref-type="bibr" rid="B218">2018</xref>). It is unclear whether this gestational age dependent response is related to the higher counts of circulating mononuclear cells found in the extremely preterm group.</p>
<p>Conversely, the excessive activation of the inflammasome and release of pro-inflammatory cytokines in neonatal sepsis, can lead to multi-organ failure and death (Gentile et al., <xref ref-type="bibr" rid="B72">2015</xref>). Caspase-1/11 knockout mice (P5-7) exposed to cecal slurry to induce polymicrobial intra-abdominal neonatal sepsis had greater survival rates compared to wild type mice (Gentile et al., <xref ref-type="bibr" rid="B72">2015</xref>). Additionally, there was reduced IL-1β and IL-18 release at 2, 6, 18, and 24 h after the induction of sepsis. Surprisingly, genetic ablation of ASC or NLRP3 was not associated with a protective effect (Gentile et al., <xref ref-type="bibr" rid="B72">2015</xref>). The knockout of ASC or NLRP3 may be insufficient for the complete elimination of caspase 1 activity as it is not solely activated by the NLRP3 inflammasome (Gentile et al., <xref ref-type="bibr" rid="B72">2015</xref>). Further adverse effects are evidenced from infants who have rare genetic mutations leading to over activation of the NLRP3 inflammasome which manifests as neonatal-onset multi-system inflammatory disease (Aróstegui et al., <xref ref-type="bibr" rid="B3">2010</xref>).</p>
<p>Recent evidence has demonstrated that increased inflammasome activity is associated with chorioamnionitis (Gomez-Lopez et al., <xref ref-type="bibr" rid="B76">2017</xref>). A study of 70 pregnant women who had undergone preterm labor showed that the chorioamniotic membranes from those with acute histological chorioamnionitis compared to those without, had greater mRNA levels of inflammasome components, including NLRP3, and other NLR proteins, caspase 1, IL-1β, IL-18, and increased ASC and caspase 1 complex formation (Gomez-Lopez et al., <xref ref-type="bibr" rid="B76">2017</xref>). Additionally, a study of amniotic fluid from 143 women showed that those who had undergone spontaneous preterm labor, with intra-amniotic infection/inflammation (positive culture for microorganisms in the amniotic fluid, or a white blood cell count of &gt;100 cells/mm<sup>3</sup>) had significantly higher caspase 1 levels compared to those without intra-amniotic infection/inflammation, delivering at term or preterm (Gotsch et al., <xref ref-type="bibr" rid="B78">2008</xref>). Furthermore, umbilical cord blood monocytes from preterm infants with histological chorioamnionitis showed reduced caspase 1 activity compared to those without histological chorioamnionitis (Sharma et al., <xref ref-type="bibr" rid="B166">2015</xref>).</p>
<p>Although NLRP3 mediated inflammation may be implicated in many diseases, further study of its involvement in perinatal brain injury after HI and infection/inflammation is necessary. Disentangling the temporal effects of inflammation is particularly important, as discussed earlier the role of inflammation can be both beneficial and deleterious.</p>
</sec>
</sec>
<sec id="s11" sec-type="conclusions">
<title>Conclusion</title>
<p>Connexin and pannexin membrane channels can contribute to the evolution of perinatal brain injury. Connexin hemichannel, and to a lesser extent pannexin channel, blockade, has been associated with neuroprotection in a number of models of brain injury. A potential mechanism of injury perpetuated by connexin hemichannels could be release of what may be a key inflammasome signal 2 activator, ATP. Extracellular ATP activates purinergic receptors, which in turn have been shown to be involved with the activation of microglia and the inflammasome complex. Blockade of purinergic receptors P2X4 and P2X7 has been protective in adult animal models of stroke but further studies are required to investigate the involvement of purinergic receptors in the propagation of perinatal brain injury, and in particular the timing of their contribution to spreading injury. However, although P2X4R and P2X7R have been implicated in microglial activation following HI insults, and could be targets for modulating microglial responses after perinatal brain injury, connexin hemichannel perpetuation of the inflammasome would be upstream of both. Increasing evidence suggests that modulating the cascade upstream of inflammasome activation may attenuate brain injury mediated through inflammation. Inflammasome activation should be investigated further in perinatal brain injury, as it may be an important mediator of deleterious inflammatory responses.</p>
</sec>
<sec id="s12">
<title>Author Contributions</title>
<p>JD and KZ conceptualized this topical review. KZ, JD, AG, LB, and CG undertook manuscript writing and preparation of figures. All authors reviewed and edited this manuscript.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>CG has intellectual property related to connexin hemichannel and pannexin channel modulation for the treatment of inflammatory disease and regulation of the inflammasome pathway and is a co-founder of OcuNexus Therapeutics, which has a focus on the treatment of chronic disease indications. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The authors' studies discussed in this review was funded by The Health Research Council of New Zealand, grant numbers: 16/003, 12/613, 14/216, 17/601 and the Marsden Fund, grant number 17-UOA232. JD holds a Sir Charles Hercus Fellowship from the Health Research Council of New Zealand (16/003). CG acknowledges support from Wendy and Bruce Hadden. KZ was supported by a University of Auckland Doctoral Scholarship.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>D. B.</given-names></name><name><surname>Goldberg</surname><given-names>G. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Transfer of biologically important molecules between cells through gap junction channels</article-title>. <source/>Curr. Med. Chem.
<volume>10</volume>, <fpage>2045</fpage>–<lpage>2058</lpage>. <pub-id pub-id-type="doi">10.2174/0929867033456927</pub-id><pub-id pub-id-type="pmid">12871102</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbeloa</surname><given-names>J.</given-names></name><name><surname>Pérez-Samartín</surname><given-names>A.</given-names></name><name><surname>Gottlieb</surname><given-names>M.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia</article-title>. <source/>Neurobiol. Dis.
<volume>45</volume>, <fpage>954</fpage>–<lpage>961</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2011.12.014</pub-id><pub-id pub-id-type="pmid">22186422</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aróstegui</surname><given-names>J. I.</given-names></name><name><surname>Lopez Saldana</surname><given-names>M. D.</given-names></name><name><surname>Pascal</surname><given-names>M.</given-names></name><name><surname>Clemente</surname><given-names>D.</given-names></name><name><surname>Aymerich</surname><given-names>M.</given-names></name><name><surname>Balaguer</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases</article-title>. <source/>Arthritis Rheum.
<volume>62</volume>, <fpage>1158</fpage>–<lpage>1166</lpage>. <pub-id pub-id-type="doi">10.1002/art.27342</pub-id><pub-id pub-id-type="pmid">20131270</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzopardi</surname><given-names>D.</given-names></name><name><surname>Wyatt</surname><given-names>J. S.</given-names></name><name><surname>Cady</surname><given-names>E. B.</given-names></name><name><surname>Delpy</surname><given-names>D. T.</given-names></name><name><surname>Baudin</surname><given-names>J.</given-names></name><name><surname>Stewart</surname><given-names>A. L.</given-names></name><etal></etal></person-group>. (<year>1989</year>). <article-title>Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy</article-title>. <source/>Pediatr. Res.
<volume>25</volume>, <fpage>445</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-198905000-00004</pub-id><pub-id pub-id-type="pmid">2717259</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baburamani</surname><given-names>A. A.</given-names></name><name><surname>Supramaniam</surname><given-names>V. G.</given-names></name><name><surname>Hagberg</surname><given-names>H.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglia toxicity in preterm brain injury</article-title>. <source/>Reprod. Toxicol.
<volume>48</volume>, <fpage>106</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2014.04.002</pub-id><pub-id pub-id-type="pmid">24768662</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>H. Y.</given-names></name><name><surname>Li</surname><given-names>A. P.</given-names></name></person-group> (<year>2013</year>). <article-title>P2X(7) receptors in cerebral ischemia</article-title>. <source/>Neurosci. Bull.
<volume>29</volume>, <fpage>390</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-013-1338-7</pub-id><pub-id pub-id-type="pmid">23640286</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bainbridge</surname><given-names>A.</given-names></name><name><surname>Tachtsidis</surname><given-names>I.</given-names></name><name><surname>Faulkner</surname><given-names>S. D.</given-names></name><name><surname>Price</surname><given-names>D.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Baer</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Brain mitochondrial oxidative metabolism during and after cerebral hypoxia-ischemia studied by simultaneous phosphorus magnetic-resonance and broadband near-infrared spectroscopy</article-title>. <source/>Neuroimage
<volume>102</volume>, <fpage>173</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.08.016</pub-id><pub-id pub-id-type="pmid">23959202</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>L.</given-names></name><name><surname>Locovei</surname><given-names>S.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Pannexin membrane channels are mechanosensitive conduits for ATP</article-title>. <source/>FEBS Lett.
<volume>572</volume>, <fpage>65</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2004.07.009</pub-id><pub-id pub-id-type="pmid">15304325</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barakat</surname><given-names>R.</given-names></name><name><surname>Redzic</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>). <article-title>Differential cytokine expression by brain microglia/macrophages in primary culture after oxygen glucose deprivation and their protective effects on astrocytes during anoxia</article-title>. <source/>Fluids Barriers CNS
<volume>12</volume>:<fpage>6</fpage>. <pub-id pub-id-type="doi">10.1186/s12987-015-0002-1</pub-id><pub-id pub-id-type="pmid">25866619</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baroja-Mazo</surname><given-names>A.</given-names></name><name><surname>Barberà-Cremades</surname><given-names>M.</given-names></name><name><surname>Pelegrin</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>The participation of plasma membrane hemichannels to purinergic signaling</article-title>. <source/>Biochim. Biophys. Acta
<volume>1828</volume>, <fpage>79</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2012.01.002</pub-id><pub-id pub-id-type="pmid">22266266</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartha</surname><given-names>A. I.</given-names></name><name><surname>Foster-Barber</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>S. P.</given-names></name><name><surname>Vigneron</surname><given-names>D. B.</given-names></name><name><surname>Glidden</surname><given-names>D. V.</given-names></name><name><surname>Barkovich</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome</article-title>. <source/>Pediatr. Res.
<volume>56</volume>, <fpage>960</fpage>–<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1203/01.PDR.0000144819.45689.BB</pub-id><pub-id pub-id-type="pmid">15496611</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Booth</surname><given-names>L.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Potential biomarkers for hypoxic-ischemic encephalopathy</article-title>. <source/>Semin. Fetal Neonatal Med.
<volume>15</volume>, <fpage>253</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/j.siny.2010.05.007</pub-id><pub-id pub-id-type="pmid">20646975</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Dhillon</surname><given-names>S.</given-names></name><name><surname>Lear</surname><given-names>C. A.</given-names></name><name><surname>Van Den Heuij</surname><given-names>L.</given-names></name><name><surname>King</surname><given-names>V.</given-names></name><name><surname>Dean</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Chronic inflammation and impaired development of the preterm brain</article-title>. <source/>J. Reprod. Immunol.
<volume>125</volume>, <fpage>45</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.jri.2017.11.003</pub-id><pub-id pub-id-type="pmid">29253793</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Roelfsema</surname><given-names>V.</given-names></name><name><surname>Pathipati</surname><given-names>P.</given-names></name><name><surname>Quaedackers</surname><given-names>J.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Relationship between evolving epileptiform activity and delayed loss of mitochondrial activity after asphyxia measured by near-infrared spectroscopy in preterm fetal sheep</article-title>. <source/>J. Physiol.
<volume>572</volume>, <fpage>141</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2006.105197</pub-id><pub-id pub-id-type="pmid">16484298</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Garré</surname><given-names>J. M.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Bukauskas</surname><given-names>F. F.</given-names></name><name><surname>Nedergaard</surname><given-names>M.</given-names></name><name><surname>Saez</surname><given-names>J. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Connexin and pannexin hemichannels in inflammatory responses of glia and neurons</article-title>. <source/>Brain Res.
<volume>1487</volume>, <fpage>3</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.08.042</pub-id><pub-id pub-id-type="pmid">22975435</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bo</surname><given-names>X.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Nori</surname><given-names>S. L.</given-names></name><name><surname>Schoepfer</surname><given-names>R.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name><name><surname>North</surname><given-names>R. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Tissue distribution of P2X4 receptors studied with an ectodomain antibody</article-title>. <source/>Cell Tissue Res.
<volume>313</volume>, <fpage>159</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-003-0758-5</pub-id><pub-id pub-id-type="pmid">12845522</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boassa</surname><given-names>D.</given-names></name><name><surname>Ambrosi</surname><given-names>C.</given-names></name><name><surname>Qiu</surname><given-names>F.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name><name><surname>Gaietta</surname><given-names>G.</given-names></name><name><surname>Sosinsky</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane</article-title>. <source/>J. Biol. Chem.
<volume>282</volume>, <fpage>31733</fpage>–<lpage>31743</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M702422200</pub-id><pub-id pub-id-type="pmid">17715132</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bona</surname><given-names>E.</given-names></name><name><surname>Andersson</surname><given-names>A. L.</given-names></name><name><surname>Blomgren</surname><given-names>K.</given-names></name><name><surname>Gilland</surname><given-names>E.</given-names></name><name><surname>Puka-Sundvall</surname><given-names>M.</given-names></name><name><surname>Gustafson</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats</article-title>. <source/>Pediatr. Res.
<volume>45</volume>, <fpage>500</fpage>–<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199904010-00008</pub-id><pub-id pub-id-type="pmid">10203141</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonestroo</surname><given-names>H. J.</given-names></name><name><surname>Nijboer</surname><given-names>C. H.</given-names></name><name><surname>van Velthoven</surname><given-names>C. T.</given-names></name><name><surname>Kavelaars</surname><given-names>A.</given-names></name><name><surname>Hack</surname><given-names>C. E.</given-names></name><name><surname>Van Bel</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats</article-title>. <source/>Dev. Neurosci.
<volume>35</volume>, <fpage>197</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1159/000346685</pub-id><pub-id pub-id-type="pmid">23689428</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bours</surname><given-names>M. J.</given-names></name><name><surname>Dagnelie</surname><given-names>P. C.</given-names></name><name><surname>Giuliani</surname><given-names>A. L.</given-names></name><name><surname>Wesselius</surname><given-names>A.</given-names></name><name><surname>Di Virgilio</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation</article-title>. <source/>Front. Biosci. (Schol. Ed.)
<volume>3</volume>, <fpage>1443</fpage>–<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.2741/s235</pub-id><pub-id pub-id-type="pmid">21622280</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruzzone</surname><given-names>R.</given-names></name><name><surname>Hormuzdi</surname><given-names>S. G.</given-names></name><name><surname>Barbe</surname><given-names>M. T.</given-names></name><name><surname>Herb</surname><given-names>A.</given-names></name><name><surname>Monyer</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Pannexins, a family of gap junction proteins expressed in brain</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>100</volume>, <fpage>13644</fpage>–<lpage>13649</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2233464100</pub-id><pub-id pub-id-type="pmid">14597722</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnstock</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Purinergic cotransmission</article-title>. <source/>F1000 Biol. Rep.
<volume>1</volume>:<fpage>46</fpage>. <pub-id pub-id-type="doi">10.3410/B1-46</pub-id><pub-id pub-id-type="pmid">20948639</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaliere</surname><given-names>F.</given-names></name><name><surname>Florenzano</surname><given-names>F.</given-names></name><name><surname>Amadio</surname><given-names>S.</given-names></name><name><surname>Fusco</surname><given-names>F. R.</given-names></name><name><surname>Viscomi</surname><given-names>M. T.</given-names></name><name><surname>D'ambrosi</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists</article-title>. <source/>Neuroscience
<volume>120</volume>, <fpage>85</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(03)00228-8</pub-id><pub-id pub-id-type="pmid">12849743</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cea</surname><given-names>L. A.</given-names></name><name><surname>Balboa</surname><given-names>E.</given-names></name><name><surname>Puebla</surname><given-names>C.</given-names></name><name><surname>Vargas</surname><given-names>A. A.</given-names></name><name><surname>Cisterna</surname><given-names>B. A.</given-names></name><name><surname>Escamilla</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Dexamethasone-induced muscular atrophy is mediated by functional expression of connexin-based hemichannels</article-title>. <source/>Biochim. Biophys. Acta
<volume>1862</volume>, <fpage>1891</fpage>–<lpage>1899</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2016.07.003</pub-id><pub-id pub-id-type="pmid">27437607</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>A.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Franchi</surname><given-names>L.</given-names></name><name><surname>Loo</surname><given-names>Y. M.</given-names></name><name><surname>Gale</surname><given-names>M.</given-names><suffix>Jr.</suffix></name><name><surname>Nunez</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>RNase L activates the NLRP3 inflammasome during viral infections</article-title>. <source/>Cell Host Microbe
<volume>17</volume>, <fpage>466</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2015.02.010</pub-id><pub-id pub-id-type="pmid">25816776</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chekeni</surname><given-names>F. B.</given-names></name><name><surname>Elliott</surname><given-names>M. R.</given-names></name><name><surname>Sandilos</surname><given-names>J. K.</given-names></name><name><surname>Walk</surname><given-names>S. F.</given-names></name><name><surname>Kinchen</surname><given-names>J. M.</given-names></name><name><surname>Lazarowski</surname><given-names>E. R.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis</article-title>. <source/>Nature
<volume>467</volume>, <fpage>863</fpage>–<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1038/nature09413</pub-id><pub-id pub-id-type="pmid">20944749</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Ginkgolide B ameliorates NLRP3 inflammasome activation after hypoxic-ischemic brain injury in the neonatal male rat</article-title>. <source/>Int. J. Dev. Neurosci.
<volume>69</volume>, <fpage>106</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2018.07.004</pub-id><pub-id pub-id-type="pmid">30030129</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>R. D.</given-names></name><name><surname>Ren</surname><given-names>J. J.</given-names></name><name><surname>Zhang</surname><given-names>Y. Y.</given-names></name><name><surname>Ye</surname><given-names>X. M.</given-names></name></person-group> (<year>2014</year>). <article-title>P2X4 receptors expressed on microglial cells in post-ischemic inflammation of brain ischemic injury</article-title>. <source/>Neurochem. Int.
<volume>67</volume>, <fpage>9</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2014.01.011</pub-id><pub-id pub-id-type="pmid">24486458</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherry</surname><given-names>J. D.</given-names></name><name><surname>Olschowka</surname><given-names>J. A.</given-names></name><name><surname>O'banion</surname><given-names>M. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuroinflammation and M2 microglia: the good, the bad, and the inflamed</article-title>. <source/>J. Neuroinflammation
<volume>11</volume>:<fpage>98</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-11-98</pub-id><pub-id pub-id-type="pmid">24889886</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>K.</given-names></name><name><surname>Yin</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>G.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus</article-title>. <source/>J. Neuroinflammation
<volume>9</volume>:<fpage>69</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-69</pub-id><pub-id pub-id-type="pmid">22513224</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cikla</surname><given-names>U.</given-names></name><name><surname>Chanana</surname><given-names>V.</given-names></name><name><surname>Kintner</surname><given-names>D. B.</given-names></name><name><surname>Covert</surname><given-names>L.</given-names></name><name><surname>Dewall</surname><given-names>T.</given-names></name><name><surname>Waldman</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Suppression of microglia activation after hypoxia-ischemia results in age-dependent improvements in neurologic injury</article-title>. <source/>J. Neuroimmunol.
<volume>291</volume>, <fpage>18</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2015.12.004</pub-id><pub-id pub-id-type="pmid">26857490</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cisneros-Mejorado</surname><given-names>A.</given-names></name><name><surname>Gottlieb</surname><given-names>M.</given-names></name><name><surname>Cavaliere</surname><given-names>F.</given-names></name><name><surname>Magnus</surname><given-names>T.</given-names></name><name><surname>Koch-Nolte</surname><given-names>F.</given-names></name><name><surname>Scemes</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015a</year>). <article-title>Blockade of P2X7 receptors or pannexin-1 channels similarly attenuates postischemic damage</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>35</volume>, <fpage>843</fpage>–<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2014.262</pub-id><pub-id pub-id-type="pmid">25605289</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cisneros-Mejorado</surname><given-names>A.</given-names></name><name><surname>Pérez-Samartín</surname><given-names>A.</given-names></name><name><surname>Gottlieb</surname><given-names>M.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2015b</year>). <article-title>ATP signaling in brain: release, excitotoxicity and potential therapeutic targets</article-title>. <source/>Cell. Mol. Neurobiol.
<volume>35</volume>, <fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-014-0092-3</pub-id><pub-id pub-id-type="pmid">25096398</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>J. E.</given-names></name><name><surname>Sánchez</surname><given-names>H. A.</given-names></name><name><surname>Eugenin</surname><given-names>E. A.</given-names></name><name><surname>Speidel</surname><given-names>D.</given-names></name><name><surname>Theis</surname><given-names>M.</given-names></name><name><surname>Willecke</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>99</volume>, <fpage>495</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.012589799</pub-id><pub-id pub-id-type="pmid">11756680</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>R.</given-names></name><name><surname>Signorino</surname><given-names>G.</given-names></name><name><surname>Malara</surname><given-names>A.</given-names></name><name><surname>Cardile</surname><given-names>F.</given-names></name><name><surname>Biondo</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Activation of the NLRP3 inflammasome by group B streptococci</article-title>. <source/>J. Immunol.
<volume>188</volume>, <fpage>1953</fpage>–<lpage>1960</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1102543</pub-id><pub-id pub-id-type="pmid">22250086</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruikshank</surname><given-names>S. J.</given-names></name><name><surname>Hopperstad</surname><given-names>M.</given-names></name><name><surname>Younger</surname><given-names>M.</given-names></name><name><surname>Connors</surname><given-names>B. W.</given-names></name><name><surname>Spray</surname><given-names>D. C.</given-names></name><name><surname>Srinivas</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Potent block of Cx36 and Cx50 gap junction channels by mefloquine</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>101</volume>, <fpage>12364</fpage>–<lpage>12369</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0402044101</pub-id><pub-id pub-id-type="pmid">15297615</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czeh</surname><given-names>M.</given-names></name><name><surname>Gressens</surname><given-names>P.</given-names></name><name><surname>Kaindl</surname><given-names>A. M.</given-names></name></person-group> (<year>2011</year>). <article-title>The yin and yang of microglia</article-title>. <source/>Dev. Neurosci.
<volume>33</volume>, <fpage>199</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1159/000328989</pub-id><pub-id pub-id-type="pmid">21757877</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Dean</surname><given-names>J. M.</given-names></name><name><surname>Fraser</surname><given-names>M.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Andelius</surname><given-names>T. C.</given-names></name><name><surname>Dhillon</surname><given-names>S. K.</given-names></name><etal></etal></person-group>. (<year>2018a</year>). <article-title>Perinatal brain injury: mechanisms and therapeutic approaches</article-title>. <source/>Front. Biosci. (Landmark Ed.)
<volume>23</volume>, <fpage>2204</fpage>–<lpage>2226</lpage>. <pub-id pub-id-type="doi">10.2741/4700</pub-id><pub-id pub-id-type="pmid">29772556</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Draghi</surname><given-names>V.</given-names></name><name><surname>Whitham</surname><given-names>S.</given-names></name><name><surname>Dhillon</surname><given-names>S. K.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2018b</year>). <article-title>How long is sufficient for optimal neuroprotection with cerebral cooling after ischemia in fetal sheep?</article-title>
<source/>J. Cereb. Blood Flow Metab.
<volume>38</volume>, <fpage>1047</fpage>–<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X17707671</pub-id><pub-id pub-id-type="pmid">28504050</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Drury</surname><given-names>P. P.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Nicholson</surname><given-names>L. F.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Connexin hemichannel blockade is neuroprotective after asphyxia in preterm fetal sheep</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e96558</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0096558</pub-id><pub-id pub-id-type="pmid">24865217</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Nicholson</surname><given-names>L. F.</given-names></name><name><surname>Danesh-Meyer</surname><given-names>H.</given-names></name><name><surname>Carroll</surname><given-names>S. J.</given-names></name><etal></etal></person-group>. (<year>2013a</year>). <article-title>A key role for connexin hemichannels in spreading ischemic brain injury</article-title>. <source/>Curr. Drug Targets
<volume>14</volume>, <fpage>36</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.2174/138945013804806479</pub-id><pub-id pub-id-type="pmid">23170795</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Nicholson</surname><given-names>L. F.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2013b</year>). <article-title>Connexin hemichannel blockade is neuroprotective after, but not during, global cerebral ischemia in near-term fetal sheep</article-title>. <source/>Exp. Neurol.
<volume>248</volume>, <fpage>301</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2013.06.026</pub-id><pub-id pub-id-type="pmid">23838537</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Nicholson</surname><given-names>L. F.</given-names></name><name><surname>O'carroll</surname><given-names>S. J.</given-names></name><name><surname>Fraser</surname><given-names>M.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Connexin hemichannel blockade improves outcomes in a model of fetal ischemia</article-title>. <source/>Ann. Neurol.
<volume>71</volume>, <fpage>121</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22654</pub-id><pub-id pub-id-type="pmid">22275258</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Rout</surname><given-names>A. L.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Yuill</surname><given-names>C. A.</given-names></name><name><surname>Zhang</surname><given-names>F. G.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><etal></etal></person-group>. (<year>2015a</year>). <article-title>Non-additive effects of delayed connexin hemichannel blockade and hypothermia after cerebral ischemia in near-term fetal sheep</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>35</volume>, <fpage>2052</fpage>–<lpage>2061</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2015.171</pub-id><pub-id pub-id-type="pmid">26174327</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Van Den Heuij</surname><given-names>L. G.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2015b</year>). <article-title>Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy–where to from here?</article-title>
<source/>Front. Neurol.
<volume>6</volume>:<fpage>198</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2015.00198</pub-id><pub-id pub-id-type="pmid">26441818</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Yuill</surname><given-names>C. A.</given-names></name><name><surname>Zhang</surname><given-names>F. G.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2015c</year>). <article-title>How long is too long for cerebral cooling after ischemia in fetal sheep?</article-title>
<source/>J. Cereb. Blood Flow Metab.
<volume>35</volume>, <fpage>751</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2014.259</pub-id><pub-id pub-id-type="pmid">25605291</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Yuill</surname><given-names>C. A.</given-names></name><name><surname>Zhang</surname><given-names>F. G.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Extending the duration of hypothermia does not further improve white matter protection after ischemia in term-equivalent fetal sheep</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>25178</fpage>
<pub-id pub-id-type="doi">10.1038/srep25178</pub-id><pub-id pub-id-type="pmid">27121655</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>De Bock</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Bultynck</surname><given-names>G.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Connexin and pannexin signaling pathways, an architectural blueprint for CNS physiology and pathology?</article-title>
<source/>Cell. Mol. Life Sci.
<volume>72</volume>, <fpage>2823</fpage>–<lpage>2851</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-015-1962-7</pub-id><pub-id pub-id-type="pmid">26118660</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>De Vuyst</surname><given-names>E.</given-names></name><name><surname>Vinken</surname><given-names>M.</given-names></name><name><surname>Van Moorhem</surname><given-names>M.</given-names></name><name><surname>Vranckx</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model</article-title>. <source/>Cell Death Differ.
<volume>16</volume>, <fpage>151</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2008.138</pub-id><pub-id pub-id-type="pmid">18820645</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denker</surname><given-names>S. P.</given-names></name><name><surname>Ji</surname><given-names>S.</given-names></name><name><surname>Dingman</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>S. Y.</given-names></name><name><surname>Derugin</surname><given-names>N.</given-names></name><name><surname>Wendland</surname><given-names>M. F.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke</article-title>. <source/>J. Neurochem.
<volume>100</volume>, <fpage>893</fpage>–<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04162.x</pub-id><pub-id pub-id-type="pmid">17212701</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dermietzel</surname><given-names>R.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Scemes</surname><given-names>E.</given-names></name><name><surname>Vieira</surname><given-names>D.</given-names></name><name><surname>Urban</surname><given-names>M.</given-names></name><name><surname>Kremer</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Connexin43 null mice reveal that astrocytes express multiple connexins</article-title>. <source/>Brain Res. Brain Res. Rev.
<volume>32</volume>, <fpage>45</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-0173(99)00067-3</pub-id><pub-id pub-id-type="pmid">10751656</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Virgilio</surname><given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Liaisons dangereuses: P2X(7) and the inflammasome</article-title>. <source/>Trends Pharmacol. Sci.
<volume>28</volume>, <fpage>465</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2007.07.002</pub-id><pub-id pub-id-type="pmid">17692395</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drury</surname><given-names>P. P.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Booth</surname><given-names>L. C.</given-names></name><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Maturation of the mitochondrial redox response to profound asphyxia in fetal sheep</article-title>. <source/>PLOS ONE
<volume>7</volume>:<fpage>e39273</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0039273</pub-id><pub-id pub-id-type="pmid">22720088</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>A. D.</given-names></name><name><surname>Brocklehurst</surname><given-names>P.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name><name><surname>Halliday</surname><given-names>H.</given-names></name><name><surname>Juszczak</surname><given-names>E.</given-names></name><name><surname>Levene</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data</article-title>. <source/>BMJ
<volume>340</volume>:<fpage>c363</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.c363</pub-id><pub-id pub-id-type="pmid">20144981</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>T. M.</given-names></name><name><surname>Khakh</surname><given-names>B. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Contribution of calcium ions to P2X channel responses</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>3413</fpage>–<lpage>3420</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5429-03.2004</pub-id><pub-id pub-id-type="pmid">15056721</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>W. H.</given-names></name><name><surname>De Vuyst</surname><given-names>E.</given-names></name><name><surname>Leybaert</surname><given-names>L.</given-names></name></person-group> (<year>2006</year>). <article-title>The gap junction cellular internet: connexin hemichannels enter the signalling limelight</article-title>. <source/>Biochem. J.
<volume>397</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20060175</pub-id><pub-id pub-id-type="pmid">16761954</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>R.</given-names></name><name><surname>Fu</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite</article-title>. <source/>J. Neuroinflammation
<volume>12</volume>:<fpage>190</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0409-2</pub-id><pub-id pub-id-type="pmid">26475134</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrazzano</surname><given-names>P.</given-names></name><name><surname>Chanana</surname><given-names>V.</given-names></name><name><surname>Uluc</surname><given-names>K.</given-names></name><name><surname>Fidan</surname><given-names>E.</given-names></name><name><surname>Akture</surname><given-names>E.</given-names></name><name><surname>Kintner</surname><given-names>D. B.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Age-dependent microglial activation in immature brains after hypoxia- ischemia</article-title>. <source/>CNS Neurol. Disord. Drug Targets
<volume>12</volume>, <fpage>338</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.2174/1871527311312030007</pub-id><pub-id pub-id-type="pmid">23469850</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleiss</surname><given-names>B.</given-names></name><name><surname>Gressens</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy?</article-title>
<source/>Lancet Neurol.
<volume>11</volume>, <fpage>556</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(12)70058-3</pub-id><pub-id pub-id-type="pmid">22608669</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster-Barber</surname><given-names>A.</given-names></name><name><surname>Dickens</surname><given-names>B.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome</article-title>. <source/>Dev. Neurosci.
<volume>23</volume>, <fpage>213</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1159/000046146</pub-id><pub-id pub-id-type="pmid">11598323</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franchi</surname><given-names>L.</given-names></name><name><surname>Eigenbrod</surname><given-names>T.</given-names></name><name><surname>Núñez</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation</article-title>. <source/>J. Immunol.
<volume>183</volume>, <fpage>792</fpage>–<lpage>796</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900173</pub-id><pub-id pub-id-type="pmid">19542372</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franke</surname><given-names>H.</given-names></name><name><surname>Günther</surname><given-names>A.</given-names></name><name><surname>Grosche</surname><given-names>J.</given-names></name><name><surname>Schmidt</surname><given-names>R.</given-names></name><name><surname>Rossner</surname><given-names>S.</given-names></name><name><surname>Reinhardt</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>P2X7 receptor expression after ischemia in the cerebral cortex of rats</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>63</volume>, <fpage>686</fpage>–<lpage>699</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/63.7.686</pub-id><pub-id pub-id-type="pmid">15290894</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>L. C.</given-names></name><name><surname>Ting</surname><given-names>J. P.</given-names></name></person-group> (<year>2016</year>). <article-title>The pathogenic role of the inflammasome in neurodegenerative diseases</article-title>. <source/>J. Neurochem.
<volume>136</volume>, <fpage>29</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13217</pub-id><pub-id pub-id-type="pmid">26119245</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitas-Andrade</surname><given-names>M.</given-names></name><name><surname>Bechberger</surname><given-names>J. F.</given-names></name><name><surname>Macvicar</surname><given-names>B. A.</given-names></name><name><surname>Viau</surname><given-names>V.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Pannexin1 knockout and blockade reduces ischemic stroke injury in female, but not in male mice</article-title>. <source/>Oncotarget
<volume>8</volume>, <fpage>36973</fpage>–<lpage>36983</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.16937</pub-id><pub-id pub-id-type="pmid">28445139</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frenguelli</surname><given-names>B. G.</given-names></name><name><surname>Wigmore</surname><given-names>G.</given-names></name><name><surname>Llaudet</surname><given-names>E.</given-names></name><name><surname>Dale</surname><given-names>N.</given-names></name></person-group> (<year>2007</year>). <article-title>Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus</article-title>. <source/>J. Neurochem.
<volume>101</volume>, <fpage>1400</fpage>–<lpage>1413</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04425.x</pub-id><pub-id pub-id-type="pmid">17459147</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frizzo</surname><given-names>J. K.</given-names></name><name><surname>Cardoso</surname><given-names>M. P.</given-names></name><name><surname>De Assis</surname><given-names>A. M.</given-names></name><name><surname>Perry</surname><given-names>M. L.</given-names></name><name><surname>Volonté</surname><given-names>C.</given-names></name><name><surname>Frizzo</surname><given-names>M. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of acute perinatal asphyxia in the rat hippocampus</article-title>. <source/>Cell. Mol. Neurobiol.
<volume>30</volume>, <fpage>683</fpage>–<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-009-9492-1</pub-id><pub-id pub-id-type="pmid">20099024</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumagalli</surname><given-names>S.</given-names></name><name><surname>Perego</surname><given-names>C.</given-names></name><name><surname>Pischiutta</surname><given-names>F.</given-names></name><name><surname>Zanier</surname><given-names>E. R.</given-names></name><name><surname>De Simoni</surname><given-names>M. G.</given-names></name></person-group> (<year>2015</year>). <article-title>The ischemic environment drives microglia and macrophage function</article-title>. <source/>Front. Neurol.
<volume>6</volume>:<fpage>81</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2015.00081</pub-id><pub-id pub-id-type="pmid">25904895</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galinsky</surname><given-names>R.</given-names></name><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Dean</surname><given-names>J. M.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2018a</year>). <article-title>Glia and hemichannels: key mediators of perinatal encephalopathy</article-title>. <source/>Neural Regen. Res.
<volume>13</volume>, <fpage>181</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.226378</pub-id><pub-id pub-id-type="pmid">29557357</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galinsky</surname><given-names>R.</given-names></name><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Lear</surname><given-names>C. A.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Connexin hemichannel blockade improves survival of striatal GABA-ergic neurons after global cerebral ischaemia in term-equivalent fetal sheep</article-title>. <source/>Sci. Rep.
<volume>7</volume>:<fpage>6304</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-06683-1</pub-id><pub-id pub-id-type="pmid">28740229</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galinsky</surname><given-names>R.</given-names></name><name><surname>Lear</surname><given-names>C. A.</given-names></name><name><surname>Dean</surname><given-names>J. M.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Dhillon</surname><given-names>S. K.</given-names></name><name><surname>Fraser</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2018b</year>). <article-title>Complex interactions between hypoxia-ischemia and inflammation in preterm brain injury</article-title>. <source/>Dev. Med. Child Neurol.
<volume>60</volume>, <fpage>126</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.13629</pub-id><pub-id pub-id-type="pmid">29194585</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Dong</surname><given-names>Q.</given-names></name><name><surname>Song</surname><given-names>Z.</given-names></name><name><surname>Shen</surname><given-names>F.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>NLRP3 inflammasome: a promising target in ischemic stroke</article-title>. <source/>Inflamm. Res.
<volume>66</volume>, <fpage>17</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-016-0981-7</pub-id><pub-id pub-id-type="pmid">27576327</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentile</surname><given-names>L. F.</given-names></name><name><surname>Cuenca</surname><given-names>A. L.</given-names></name><name><surname>Cuenca</surname><given-names>A. G.</given-names></name><name><surname>Nacionales</surname><given-names>D. C.</given-names></name><name><surname>Ungaro</surname><given-names>R.</given-names></name><name><surname>Efron</surname><given-names>P. A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Improved emergency myelopoiesis and survival in neonatal sepsis by caspase-1/11 ablation</article-title>. <source/>Immunology
<volume>145</volume>, <fpage>300</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12450</pub-id><pub-id pub-id-type="pmid">25684123</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilroy</surname><given-names>D.</given-names></name><name><surname>De Maeyer</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>New insights into the resolution of inflammation</article-title>. <source/>Semin. Immunol.
<volume>27</volume>, <fpage>161</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2015.05.003</pub-id><pub-id pub-id-type="pmid">26037968</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>P.</given-names></name><name><surname>Srinivas</surname><given-names>S. P.</given-names></name><name><surname>Van Driessche</surname><given-names>W.</given-names></name><name><surname>Vereecke</surname><given-names>J.</given-names></name><name><surname>Himpens</surname><given-names>B.</given-names></name></person-group> (<year>2005</year>). <article-title>ATP release through connexin hemichannels in corneal endothelial cells</article-title>. <source/>Invest. Ophthalmol. Vis. Sci.
<volume>46</volume>, <fpage>1208</fpage>–<lpage>1218</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.04-1181</pub-id><pub-id pub-id-type="pmid">15790881</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Hernández</surname><given-names>J. M.</given-names></name><name><surname>De Miguel</surname><given-names>M.</given-names></name><name><surname>Larrosa</surname><given-names>B.</given-names></name><name><surname>Gonzalez</surname><given-names>D.</given-names></name><name><surname>Barrio</surname><given-names>L. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Molecular basis of calcium regulation in connexin-32 hemichannels</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>100</volume>, <fpage>16030</fpage>–<lpage>16035</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2530348100</pub-id><pub-id pub-id-type="pmid">14663144</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N.</given-names></name><name><surname>Romero</surname><given-names>R.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Garcia-Flores</surname><given-names>V.</given-names></name><name><surname>Leng</surname><given-names>Y.</given-names></name><name><surname>Panaitescu</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Inflammasome assembly in the chorioamniotic membranes during spontaneous labor at term</article-title>. <source/>Am. J. Reprod. Immunol.
<volume>77</volume>:<fpage>e12648</fpage>. <pub-id pub-id-type="doi">10.1111/aji.12648</pub-id><pub-id pub-id-type="pmid">28233423</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Jin</surname><given-names>T.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Orchestration of NLRP3 inflammasome activation by ion fluxes</article-title>. <source/>Trends Immunol.
<volume>39</volume>, <fpage>393</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2018.01.009</pub-id><pub-id pub-id-type="pmid">29452983</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotsch</surname><given-names>F.</given-names></name><name><surname>Romero</surname><given-names>R.</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T.</given-names></name><name><surname>Erez</surname><given-names>O.</given-names></name><name><surname>Vaisbuch</surname><given-names>E.</given-names></name><name><surname>Espinoza</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturition</article-title>. <source/>J. Matern. Fetal Neonatal Med.
<volume>21</volume>, <fpage>605</fpage>–<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1080/14767050802212109</pub-id><pub-id pub-id-type="pmid">18828051</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groslambert</surname><given-names>M.</given-names></name><name><surname>Py</surname><given-names>B. F.</given-names></name></person-group> (<year>2018</year>). <article-title>Spotlight on the NLRP3 inflammasome pathway</article-title>. <source/>J. Inflamm. Res.
<volume>11</volume>, <fpage>359</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.2147/JIR.S141220</pub-id><pub-id pub-id-type="pmid">30288079</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunn</surname><given-names>A. J.</given-names></name><name><surname>Gunn</surname><given-names>T. R.</given-names></name><name><surname>De Haan</surname><given-names>H. H.</given-names></name><name><surname>Williams</surname><given-names>C. E.</given-names></name><name><surname>Gluckman</surname><given-names>P. D.</given-names></name></person-group> (<year>1997</year>). <article-title>Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs</article-title>. <source/>J. Clin. Invest.
<volume>99</volume>, <fpage>248</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1172/JCI119153</pub-id><pub-id pub-id-type="pmid">9005993</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunn</surname><given-names>A. J.</given-names></name><name><surname>Laptook</surname><given-names>A. R.</given-names></name><name><surname>Robertson</surname><given-names>N. J.</given-names></name><name><surname>Barks</surname><given-names>J. D.</given-names></name><name><surname>Thoresen</surname><given-names>M.</given-names></name><name><surname>Wassink</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Therapeutic hypothermia translates from ancient history in to practice</article-title>. <source/>Pediatr. Res.
<volume>81</volume>, <fpage>202</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2016.198</pub-id><pub-id pub-id-type="pmid">27673420</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habermacher</surname><given-names>C.</given-names></name><name><surname>Dunning</surname><given-names>K.</given-names></name><name><surname>Chataigneau</surname><given-names>T.</given-names></name><name><surname>Grutter</surname><given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Molecular structure and function of P2X receptors</article-title>. <source/>Neuropharmacology
<volume>104</volume>, <fpage>18</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.07.032</pub-id><pub-id pub-id-type="pmid">26231831</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>H.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><name><surname>Vannucci</surname><given-names>S. J.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name><name><surname>Vexler</surname><given-names>Z. S.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The role of inflammation in perinatal brain injury</article-title>. <source/>Nat. Rev. Neurol.
<volume>11</volume>, <fpage>192</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.13</pub-id><pub-id pub-id-type="pmid">25686754</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassinger</surname><given-names>T. D.</given-names></name><name><surname>Guthrie</surname><given-names>P. B.</given-names></name><name><surname>Atkinson</surname><given-names>P. B.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Kater</surname><given-names>S. B.</given-names></name></person-group> (<year>1996</year>). <article-title>An extracellular signaling component in propagation of astrocytic calcium waves</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>93</volume>, <fpage>13268</fpage>–<lpage>13273</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.23.13268</pub-id><pub-id pub-id-type="pmid">8917580</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>M.</given-names></name><name><surname>Gouaux</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular mechanism of ATP binding and ion channel activation in P2X receptors</article-title>. <source/>Nature
<volume>485</volume>, <fpage>207</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1038/nature11010</pub-id><pub-id pub-id-type="pmid">22535247</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Hara</surname><given-names>H.</given-names></name><name><surname>Núñez</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Mechanism and regulation of NLRP3 inflammasome activation</article-title>. <source/>Trends Biochem. Sci.
<volume>41</volume>, <fpage>1012</fpage>–<lpage>1021</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2016.09.002</pub-id><pub-id pub-id-type="pmid">27669650</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellström</surname><given-names>E. N.</given-names></name><name><surname>Smith</surname><given-names>P. L.</given-names></name><name><surname>Fleiss</surname><given-names>B.</given-names></name><name><surname>Nair</surname><given-names>S.</given-names></name><name><surname>Svedin</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Temporal characterization of microglia/macrophage phenotypes in a mouse model of neonatal hypoxic-ischemic brain injury</article-title>. <source/>Front. Cell. Neurosci.
<volume>10</volume>:<fpage>286</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2016.00286</pub-id><pub-id pub-id-type="pmid">28018179</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henneke</surname><given-names>P.</given-names></name><name><surname>Berner</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Interaction of neonatal phagocytes with group B streptococcus: recognition and response</article-title>. <source/>Infect. Immun.
<volume>74</volume>, <fpage>3085</fpage>–<lpage>3095</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01551-05</pub-id><pub-id pub-id-type="pmid">16714536</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>C. J.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Power</surname><given-names>G. G.</given-names></name><name><surname>Roelfsema</surname><given-names>V.</given-names></name><name><surname>Blood</surname><given-names>A. B.</given-names></name><name><surname>Quaedackers</surname><given-names>J. S.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Key neuroprotective role for endogenous adenosine A1 receptor activation during asphyxia in the fetal sheep</article-title>. <source/>Stroke
<volume>34</volume>, <fpage>2240</fpage>–<lpage>2245</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.0000083623.77327.CE</pub-id><pub-id pub-id-type="pmid">12933964</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>M.</given-names></name><name><surname>Iwamoto</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Doyle</surname><given-names>A.</given-names></name><name><surname>Fukumoto</surname><given-names>S.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Pannexin 3 functions as an ER Ca(2+) channel, hemichannel, and gap junction to promote osteoblast differentiation</article-title>. <source/>J. Cell Biol.
<volume>193</volume>, <fpage>1257</fpage>–<lpage>1274</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201101050</pub-id><pub-id pub-id-type="pmid">21690309</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ismael</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Nasoohi</surname><given-names>S.</given-names></name><name><surname>Ishrat</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke</article-title>. <source/>Sci. Rep.
<volume>8</volume>:<fpage>5971</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-24350-x</pub-id><pub-id pub-id-type="pmid">29654318</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaworska</surname><given-names>J.</given-names></name><name><surname>Ziemka-Nalecz</surname><given-names>M.</given-names></name><name><surname>Sypecka</surname><given-names>J.</given-names></name><name><surname>Zalewska</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia</article-title>. <source/>J. Neuroinflammation
<volume>14</volume>:<fpage>34</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-017-0807-8</pub-id><pub-id pub-id-type="pmid">28187734</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jian</surname><given-names>Z.</given-names></name><name><surname>Ding</surname><given-names>S.</given-names></name><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Yi</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Probenecid protects against oxygen-glucose deprivation injury in primary astrocytes by regulating inflammasome activity</article-title>. <source/>Brain Res.
<volume>1643</volume>, <fpage>123</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2016.05.002</pub-id><pub-id pub-id-type="pmid">27154322</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>E. K.</given-names></name><name><surname>Kim</surname><given-names>J. K.</given-names></name><name><surname>Shin</surname><given-names>D. M.</given-names></name><name><surname>Sasakawa</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Molecular mechanisms regulating NLRP3 inflammasome activation</article-title>. <source/>Cell Mol. Immunol.
<volume>13</volume>, <fpage>148</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2015.95</pub-id><pub-id pub-id-type="pmid">26549800</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname><given-names>H. K.</given-names></name><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Lee</surname><given-names>H. R.</given-names></name><name><surname>Choi</surname><given-names>B. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Integrin alpha5beta1 activates the NLRP3 inflammasome by direct interaction with a bacterial surface protein</article-title>. <source/>Immunity
<volume>36</volume>, <fpage>755</fpage>–<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.05.002</pub-id><pub-id pub-id-type="pmid">22608495</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>M.</given-names></name><name><surname>Penk</surname><given-names>A.</given-names></name><name><surname>Franke</surname><given-names>H.</given-names></name><name><surname>Krugel</surname><given-names>U.</given-names></name><name><surname>Norenberg</surname><given-names>W.</given-names></name><name><surname>Huster</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Lack of functional P2X7 receptor aggravates brain edema development after middle cerebral artery occlusion</article-title>. <source/>Purinergic Signal.
<volume>12</volume>, <fpage>453</fpage>–<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1007/s11302-016-9511-x</pub-id><pub-id pub-id-type="pmid">27048203</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J.</given-names></name><name><surname>Kang</surname><given-names>N.</given-names></name><name><surname>Lovatt</surname><given-names>D.</given-names></name><name><surname>Torres</surname><given-names>A.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Connexin 43 hemichannels are permeable to ATP</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>4702</fpage>–<lpage>4711</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5048-07.2008</pub-id><pub-id pub-id-type="pmid">18448647</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpuk</surname><given-names>N.</given-names></name><name><surname>Burkovetskaya</surname><given-names>M.</given-names></name><name><surname>Fritz</surname><given-names>T.</given-names></name><name><surname>Angle</surname><given-names>A.</given-names></name><name><surname>Kielian</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>414</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5247-10.2011</pub-id><pub-id pub-id-type="pmid">21228152</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname><given-names>M.</given-names><suffix>Jr.</suffix></name><name><surname>Ruskin</surname><given-names>D. N.</given-names></name><name><surname>Masino</surname><given-names>S. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>3886</fpage>–<lpage>3895</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0055-10.2010</pub-id><pub-id pub-id-type="pmid">20237259</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerur</surname><given-names>N.</given-names></name><name><surname>Fukuda</surname><given-names>S.</given-names></name><name><surname>Banerjee</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Fu</surname><given-names>D.</given-names></name><name><surname>Apicella</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>cGAS drives noncanonical-inflammasome activation in age-related macular degeneration</article-title>. <source/>Nat. Med.
<volume>24</volume>, <fpage>50</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4450</pub-id><pub-id pub-id-type="pmid">29176737</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Assessing connexin hemichannel function during ischemic injury and reperfusion</article-title>, in <source/>Gap Junction Channels and Hemichannels, eds <person-group person-group-type="editor"><name><surname>Bai</surname><given-names>D.</given-names></name><name><surname>Saez</surname><given-names>J. C.</given-names></name></person-group> (<publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC Press; Taylor &amp; Francis Group</publisher-name>), <fpage>169</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koos</surname><given-names>B. J.</given-names></name><name><surname>Kruger</surname><given-names>L.</given-names></name><name><surname>Murray</surname><given-names>T. F.</given-names></name></person-group> (<year>1997</year>). <article-title>Source of extracellular brain adenosine during hypoxia in fetal sheep</article-title>. <source/>Brain Res.
<volume>778</volume>, <fpage>439</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(97)01207-9</pub-id><pub-id pub-id-type="pmid">9459565</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korzeniewski</surname><given-names>S. J.</given-names></name><name><surname>Allred</surname><given-names>E. N.</given-names></name><name><surname>O'shea</surname><given-names>T. M.</given-names></name><name><surname>Leviton</surname><given-names>A.</given-names></name><name><surname>Kuban</surname><given-names>K. C. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Elevated protein concentrations in newborn blood and the risks of autism spectrum disorder, and of social impairment, at age 10 years among infants born before the 28th week of gestation</article-title>. <source/>Transl. Psychiatry
<volume>8</volume>:<fpage>115</fpage>. <pub-id pub-id-type="doi">10.1038/s41398-018-0156-0</pub-id><pub-id pub-id-type="pmid">29884819</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuban</surname><given-names>K. C.</given-names></name><name><surname>Joseph</surname><given-names>R. M.</given-names></name><name><surname>O'shea</surname><given-names>T. M.</given-names></name><name><surname>Heeren</surname><given-names>T.</given-names></name><name><surname>Fichorova</surname><given-names>R. N.</given-names></name><name><surname>Douglass</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Circulating inflammatory-associated proteins in the first month of life and cognitive impairment at age 10 years in children born extremely preterm</article-title>. <source/>J. Pediatr.
<volume>180</volume>, <fpage>116</fpage>–<lpage>123</lpage> e111. <pub-id pub-id-type="doi">10.1016/j.jpeds.2016.09.054</pub-id><pub-id pub-id-type="pmid">27788929</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>N. M.</given-names></name><name><surname>Gilula</surname><given-names>N. B.</given-names></name></person-group> (<year>1996</year>). <article-title>The gap junction communication channel</article-title>. <source/>Cell
<volume>84</volume>, <fpage>381</fpage>–<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81282-9</pub-id><pub-id pub-id-type="pmid">8608591</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larroque</surname><given-names>B.</given-names></name><name><surname>Ancel</surname><given-names>P. Y.</given-names></name><name><surname>Marret</surname><given-names>S.</given-names></name><name><surname>Marchand</surname><given-names>L.</given-names></name><name><surname>Andre</surname><given-names>M.</given-names></name><name><surname>Arnaud</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study</article-title>. <source/>Lancet
<volume>371</volume>, <fpage>813</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(08)60380-3</pub-id><pub-id pub-id-type="pmid">18328928</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>A. C.</given-names></name><name><surname>Kozuki</surname><given-names>N.</given-names></name><name><surname>Blencowe</surname><given-names>H.</given-names></name><name><surname>Vos</surname><given-names>T.</given-names></name><name><surname>Bahalim</surname><given-names>A.</given-names></name><name><surname>Darmstadt</surname><given-names>G. L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990</article-title>. <source/>Pediatr. Res.
<volume>74</volume>, <fpage>50</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2013.206</pub-id><pub-id pub-id-type="pmid">24366463</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. W.</given-names></name><name><surname>Gajavelli</surname><given-names>S.</given-names></name><name><surname>Spurlock</surname><given-names>M. S.</given-names></name><name><surname>Andreoni</surname><given-names>C.</given-names></name><name><surname>De Rivero Vaccari</surname><given-names>J. P.</given-names></name><name><surname>Bullock</surname><given-names>M. R.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Microglial inflammasome activation in penetrating ballistic-like brain injury</article-title>. <source/>J. Neurotrauma
<volume>35</volume>, <fpage>1681</fpage>–<lpage>1693</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2017.5530</pub-id><pub-id pub-id-type="pmid">29439605</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leybaert</surname><given-names>L.</given-names></name><name><surname>Lampe</surname><given-names>P. D.</given-names></name><name><surname>Dhein</surname><given-names>S.</given-names></name><name><surname>Kwak</surname><given-names>B. R.</given-names></name><name><surname>Ferdinandy</surname><given-names>P.</given-names></name><name><surname>Beyer</surname><given-names>E. C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Connexins in cardiovascular and neurovascular health and disease: pharmacological implications</article-title>. <source/>Pharmacol. Rev.
<volume>69</volume>, <fpage>396</fpage>–<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1124/pr.115.012062</pub-id><pub-id pub-id-type="pmid">28931622</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J. W.</given-names></name><name><surname>Gong</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Hypoxia induced amoeboid microglial cell activation in postnatal rat brain is mediated by ATP receptor P2X4</article-title>. <source/>BMC Neurosci.
<volume>12</volume>:<fpage>111</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2202-12-111</pub-id><pub-id pub-id-type="pmid">22053919</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>X.</given-names></name><name><surname>Kostrzewa</surname><given-names>R. M.</given-names></name><name><surname>Du</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Inhibition of connexin43 improves functional recovery after ischemic brain injury in neonatal rats</article-title>. <source/>Glia
<volume>63</volume>, <fpage>1553</fpage>–<lpage>1567</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22826</pub-id><pub-id pub-id-type="pmid">25988944</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C. Y.</given-names></name><name><surname>Chang</surname><given-names>Y. C.</given-names></name><name><surname>Wang</surname><given-names>S. T.</given-names></name><name><surname>Lee</surname><given-names>T. Y.</given-names></name><name><surname>Lin</surname><given-names>C. F.</given-names></name><name><surname>Huang</surname><given-names>C. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Altered inflammatory responses in preterm children with cerebral palsy</article-title>. <source/>Ann. Neurol.
<volume>68</volume>, <fpage>204</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22049</pub-id><pub-id pub-id-type="pmid">20695013</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorek</surname><given-names>A.</given-names></name><name><surname>Takei</surname><given-names>Y.</given-names></name><name><surname>Cady</surname><given-names>E. B.</given-names></name><name><surname>Wyatt</surname><given-names>J. S.</given-names></name><name><surname>Penrice</surname><given-names>J.</given-names></name><name><surname>Edwards</surname><given-names>A. D.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Delayed (“secondary”) cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy</article-title>. <source/>Pediatr. Res.
<volume>36</volume>, <fpage>699</fpage>–<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199412000-00003</pub-id><pub-id pub-id-type="pmid">7898977</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maatouk</surname><given-names>L.</given-names></name><name><surname>Yi</surname><given-names>C.</given-names></name><name><surname>Carrillo-De Sauvage</surname><given-names>M. A.</given-names></name><name><surname>Compagnion</surname><given-names>A. C.</given-names></name><name><surname>Hunot</surname><given-names>S.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity</article-title>. <source/>Cell Death Differ.
<volume>26</volume>, <fpage>580</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1038/s41418-018-0150-3</pub-id><pub-id pub-id-type="pmid">30006609</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mächler</surname><given-names>P.</given-names></name><name><surname>Wyss</surname><given-names>M. T.</given-names></name><name><surname>Elsayed</surname><given-names>M.</given-names></name><name><surname>Stobart</surname><given-names>J.</given-names></name><name><surname>Gutierrez</surname><given-names>R.</given-names></name><name><surname>Von Faber-Castell</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title><italic>In vivo</italic> evidence for a lactate gradient from astrocytes to neurons</article-title>. <source/>Cell Metab.
<volume>23</volume>, <fpage>94</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.10.010</pub-id><pub-id pub-id-type="pmid">26698914</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Tan</surname><given-names>S.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Robertson</surname><given-names>N. J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Astrocytes and microglia in acute cerebral injury underlying cerebral palsy associated with preterm birth</article-title>. <source/>Pediatr. Res.
<volume>75</volume>, <fpage>234</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2013.188</pub-id><pub-id pub-id-type="pmid">24336433</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Tremblay</surname><given-names>M. E.</given-names></name><name><surname>Vexler</surname><given-names>Z. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglia and neonatal brain injury</article-title>. <source/>Neuroscience. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.01.023</pub-id>. [Epub ahead of print].</mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>Y.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Tonkin</surname><given-names>R. S.</given-names></name><name><surname>Lees</surname><given-names>J. G.</given-names></name><name><surname>Warren</surname><given-names>C.</given-names></name><name><surname>O'carroll</surname><given-names>S. J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats</article-title>. <source/>Exp. Brain Res.
<volume>235</volume>, <fpage>3033</fpage>–<lpage>3048</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-017-5023-3</pub-id><pub-id pub-id-type="pmid">28725925</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markiewicz</surname><given-names>I.</given-names></name><name><surname>Lukomska</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>The role of astrocytes in the physiology and pathology of the central nervous system</article-title>. <source/>Acta Neurobiol. Exp. (Warsz).
<volume>66</volume>, <fpage>343</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="pmid">17265695</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marlow</surname><given-names>N.</given-names></name><name><surname>Wolke</surname><given-names>D.</given-names></name><name><surname>Bracewell</surname><given-names>M. A.</given-names></name><name><surname>Samara</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Neurologic and developmental disability at six years of age after extremely preterm birth</article-title>. <source/>N. Engl. J. Med.
<volume>352</volume>, <fpage>9</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa041367</pub-id><pub-id pub-id-type="pmid">15635108</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinon</surname><given-names>F.</given-names></name><name><surname>Mayor</surname><given-names>A.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>The inflammasomes: guardians of the body</article-title>. <source/>Annu. Rev. Immunol.
<volume>27</volume>, <fpage>229</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132715</pub-id><pub-id pub-id-type="pmid">19302040</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matute</surname><given-names>C.</given-names></name><name><surname>Torre</surname><given-names>I.</given-names></name><name><surname>Perez-Cerda</surname><given-names>F.</given-names></name><name><surname>Pérez-Samartín</surname><given-names>A.</given-names></name><name><surname>Alberdi</surname><given-names>E.</given-names></name><name><surname>Etxebarria</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>9525</fpage>–<lpage>9533</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0579-07.2007</pub-id><pub-id pub-id-type="pmid">17728465</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Recognition of microorganisms and activation of the immune response</article-title>. <source/>Nature
<volume>449</volume>, <fpage>819</fpage>–<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1038/nature06246</pub-id><pub-id pub-id-type="pmid">17943118</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melani</surname><given-names>A.</given-names></name><name><surname>Amadio</surname><given-names>S.</given-names></name><name><surname>Gianfriddo</surname><given-names>M.</given-names></name><name><surname>Vannucchi</surname><given-names>M. G.</given-names></name><name><surname>Volontè</surname><given-names>C.</given-names></name><name><surname>Bernardi</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>26</volume>, <fpage>974</fpage>–<lpage>982</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600250</pub-id><pub-id pub-id-type="pmid">16395292</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melani</surname><given-names>A.</given-names></name><name><surname>Corti</surname><given-names>F.</given-names></name><name><surname>Stephan</surname><given-names>H.</given-names></name><name><surname>Müller</surname><given-names>C. E.</given-names></name><name><surname>Donati</surname><given-names>C.</given-names></name><name><surname>Bruni</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Ecto-ATPase inhibition: ATP and adenosine release under physiological and ischemic <italic>in vivo</italic> conditions in the rat striatum</article-title>. <source/>Exp. Neurol.
<volume>233</volume>, <fpage>193</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.09.036</pub-id><pub-id pub-id-type="pmid">22001157</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melani</surname><given-names>A.</given-names></name><name><surname>Turchi</surname><given-names>D.</given-names></name><name><surname>Vannucchi</surname><given-names>M. G.</given-names></name><name><surname>Cipriani</surname><given-names>S.</given-names></name><name><surname>Gianfriddo</surname><given-names>M.</given-names></name><name><surname>Pedata</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>ATP extracellular concentrations are increased in the rat striatum during <italic>in vivo</italic> ischemia</article-title>. <source/>Neurochem. Int.
<volume>47</volume>, <fpage>442</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2005.05.014</pub-id><pub-id pub-id-type="pmid">16029911</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monif</surname><given-names>M.</given-names></name><name><surname>Reid</surname><given-names>C. A.</given-names></name><name><surname>Powell</surname><given-names>K. L.</given-names></name><name><surname>Smart</surname><given-names>M. L.</given-names></name><name><surname>Williams</surname><given-names>D. A.</given-names></name></person-group> (<year>2009</year>). <article-title>The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>3781</fpage>–<lpage>3791</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5512-08.2009</pub-id><pub-id pub-id-type="pmid">19321774</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mugisho</surname><given-names>O. O.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Kho</surname><given-names>D. T.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Graham</surname><given-names>E. S.</given-names></name><name><surname>Acosta</surname><given-names>M. L.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release</article-title>. <source/>Biochim. Biophys. Acta
<volume>1862</volume>, <fpage>385</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2017.11.015</pub-id><pub-id pub-id-type="pmid">29158134</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>J. I.</given-names></name><name><surname>Ionescu</surname><given-names>A. V.</given-names></name><name><surname>Lynn</surname><given-names>B. D.</given-names></name><name><surname>Rash</surname><given-names>J. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: implications from normal and connexin32 knockout mice</article-title>. <source/>Glia
<volume>44</volume>, <fpage>205</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1002/glia.10278</pub-id><pub-id pub-id-type="pmid">14603462</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>J. I.</given-names></name><name><surname>Ochalski</surname><given-names>P. A.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Hertzberg</surname><given-names>E. L.</given-names></name></person-group> (<year>1997</year>). <article-title>Evidence for the co-localization of another connexin with connexin-43 at astrocytic gap junctions in rat brain</article-title>. <source/>Neuroscience
<volume>78</volume>, <fpage>533</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(96)00584-2</pub-id><pub-id pub-id-type="pmid">9145808</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakase</surname><given-names>T.</given-names></name><name><surname>Maeda</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Nagata</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Ischemia alters the expression of connexins in the aged human brain</article-title>. <source/>J. Biomed. Biotechnol.
<volume>2009</volume>:<fpage>147946</fpage>. <pub-id pub-id-type="doi">10.1155/2009/147946</pub-id><pub-id pub-id-type="pmid">19794823</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakase</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Nagata</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>Enhanced connexin 43 immunoreactivity in penumbral areas in the human brain following ischemia</article-title>. <source/>Glia
<volume>54</volume>, <fpage>369</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20399</pub-id><pub-id pub-id-type="pmid">16886200</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natarajan</surname><given-names>G.</given-names></name><name><surname>Laptook</surname><given-names>A.</given-names></name><name><surname>Shankaran</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Therapeutic hypothermia: how can we optimize this therapy to further improve outcomes?</article-title>
<source/>Clin. Perinatol.
<volume>45</volume>, <fpage>241</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1016/j.clp.2018.01.010</pub-id><pub-id pub-id-type="pmid">29747886</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>C.</given-names></name><name><surname>Ding</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Nonresolving inflammation</article-title>. <source/>Cell
<volume>140</volume>, <fpage>871</fpage>–<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.02.029</pub-id><pub-id pub-id-type="pmid">20303877</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nedergaard</surname><given-names>M.</given-names></name></person-group> (<year>1994</year>). <article-title>Direct signaling from astrocytes to neurons in cultures of mammalian brain cells</article-title>. <source/>Science
<volume>263</volume>, <fpage>1768</fpage>–<lpage>1771</lpage>. <pub-id pub-id-type="doi">10.1126/science.8134839</pub-id><pub-id pub-id-type="pmid">8134839</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ness</surname><given-names>J. K.</given-names></name><name><surname>Romanko</surname><given-names>M. J.</given-names></name><name><surname>Rothstein</surname><given-names>R. P.</given-names></name><name><surname>Wood</surname><given-names>T. L.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors</article-title>. <source/>Dev. Neurosci.
<volume>23</volume>, <fpage>203</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1159/000046144</pub-id><pub-id pub-id-type="pmid">11598321</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmerjahn</surname><given-names>A.</given-names></name><name><surname>Kirchhoff</surname><given-names>F.</given-names></name><name><surname>Helmchen</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Resting microglial cells are highly dynamic surveillants of brain parenchyma <italic>in vivo</italic></article-title>. <source/>Science
<volume>308</volume>, <fpage>1314</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1126/science.1110647</pub-id><pub-id pub-id-type="pmid">15831717</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Northington</surname><given-names>F. J.</given-names></name><name><surname>Chavez-Valdez</surname><given-names>R.</given-names></name><name><surname>Martin</surname><given-names>L. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Neuronal cell death in neonatal hypoxia-ischemia</article-title>. <source/>Ann. Neurol.
<volume>69</volume>, <fpage>743</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22419</pub-id><pub-id pub-id-type="pmid">21520238</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Northington</surname><given-names>F. J.</given-names></name><name><surname>Zelaya</surname><given-names>M. E.</given-names></name><name><surname>O'riordan</surname><given-names>D. P.</given-names></name><name><surname>Blomgren</surname><given-names>K.</given-names></name><name><surname>Flock</surname><given-names>D. L.</given-names></name><name><surname>Hagberg</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as “continuum” phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain</article-title>. <source/>Neuroscience
<volume>149</volume>, <fpage>822</fpage>–<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.06.060</pub-id><pub-id pub-id-type="pmid">17961929</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odorcyk</surname><given-names>F. K.</given-names></name><name><surname>Nicola</surname><given-names>F.</given-names></name><name><surname>Duran-Carabali</surname><given-names>L. E.</given-names></name><name><surname>Figueiro</surname><given-names>F.</given-names></name><name><surname>Kolling</surname><given-names>J.</given-names></name><name><surname>Vizuete</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Galantamine administration reduces reactive astrogliosis and upregulates the anti-oxidant enzyme catalase in rats submitted to neonatal hypoxia ischemia</article-title>. <source/>Int. J. Dev. Neurosci.
<volume>62</volume>, <fpage>15</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2017.07.006</pub-id><pub-id pub-id-type="pmid">28760642</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Froger</surname><given-names>N.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Jiang</surname><given-names>J. X.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels</article-title>. <source/>J. Neurochem.
<volume>118</volume>, <fpage>826</fpage>–<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07210.x</pub-id><pub-id pub-id-type="pmid">21294731</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Hernandez</surname><given-names>D. E.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Velarde</surname><given-names>V.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of connexin 43 hemichannels</article-title>. <source/>Glia
<volume>58</volume>, <fpage>329</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20926</pub-id><pub-id pub-id-type="pmid">19705457</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Shea</surname><given-names>T. M.</given-names></name><name><surname>Allred</surname><given-names>E. N.</given-names></name><name><surname>Kuban</surname><given-names>K. C.</given-names></name><name><surname>Dammann</surname><given-names>O.</given-names></name><name><surname>Paneth</surname><given-names>N.</given-names></name><name><surname>Fichorova</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants</article-title>. <source/>J. Pediatr.
<volume>160</volume>, <fpage>395</fpage>–<lpage>401</lpage> e394. <pub-id pub-id-type="doi">10.1016/j.jpeds.2011.08.069</pub-id><pub-id pub-id-type="pmid">22000304</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>T.</given-names></name><name><surname>Muramatsu</surname><given-names>R.</given-names></name><name><surname>Sasai</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Kubota</surname><given-names>Y.</given-names></name><name><surname>Fujinaka</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>The P2X4 receptor is required for neuroprotection via ischemic preconditioning</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>25893</fpage>. <pub-id pub-id-type="doi">10.1038/srep25893</pub-id><pub-id pub-id-type="pmid">27173846</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panchin</surname><given-names>Y. V.</given-names></name></person-group> (<year>2005</year>). <article-title>Evolution of gap junction proteins–the pannexin alternative</article-title>. <source/>J. Exp. Biol.
<volume>208</volume>, <fpage>1415</fpage>–<lpage>1419</lpage>. <pub-id pub-id-type="doi">10.1242/jeb.01547</pub-id><pub-id pub-id-type="pmid">15802665</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>Z. R.</given-names></name><name><surname>Holahan</surname><given-names>M. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Understanding the neuroinflammatory response following concussion to develop treatment strategies</article-title>. <source/>Front. Cell. Neurosci.
<volume>6</volume>:<fpage>58</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2012.00058</pub-id><pub-id pub-id-type="pmid">23248582</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>D. L.</given-names></name><name><surname>Ebihara</surname><given-names>L.</given-names></name><name><surname>Takemoto</surname><given-names>L. J.</given-names></name><name><surname>Swenson</surname><given-names>K. I.</given-names></name><name><surname>Goodenough</surname><given-names>D. A.</given-names></name></person-group> (<year>1991</year>). <article-title>Connexin46, a novel lens gap junction protein, induces voltage-gated currents in nonjunctional plasma membrane of Xenopus oocytes</article-title>. <source/>J. Cell Biol.
<volume>115</volume>, <fpage>1077</fpage>–<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.115.4.1077</pub-id><pub-id pub-id-type="pmid">1659572</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedata</surname><given-names>F.</given-names></name><name><surname>Dettori</surname><given-names>I.</given-names></name><name><surname>Coppi</surname><given-names>E.</given-names></name><name><surname>Melani</surname><given-names>A.</given-names></name><name><surname>Fusco</surname><given-names>I.</given-names></name><name><surname>Corradetti</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Purinergic signalling in brain ischemia</article-title>. <source/>Neuropharmacology
<volume>104</volume>, <fpage>105</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.11.007</pub-id><pub-id pub-id-type="pmid">26581499</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelegrin</surname><given-names>P.</given-names></name><name><surname>Surprenant</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor</article-title>. <source/>EMBO J.
<volume>25</volume>, <fpage>5071</fpage>–<lpage>5082</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601378</pub-id><pub-id pub-id-type="pmid">17036048</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>W.</given-names></name><name><surname>Cotrina</surname><given-names>M. L.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Bekar</surname><given-names>L.</given-names></name><name><surname>Blum</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>106</volume>, <fpage>12489</fpage>–<lpage>12493</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0902531106</pub-id><pub-id pub-id-type="pmid">19666625</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierre</surname><given-names>W. C.</given-names></name><name><surname>Smith</surname><given-names>P. L.</given-names></name><name><surname>Londono</surname><given-names>I.</given-names></name><name><surname>Chemtob</surname><given-names>S.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Lodygensky</surname><given-names>G. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Neonatal microglia: the cornerstone of brain fate</article-title>. <source/>Brain. Behav. Immun.
<volume>59</volume>, <fpage>333</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.08.018</pub-id><pub-id pub-id-type="pmid">27596692</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puka-Sundvall</surname><given-names>M.</given-names></name><name><surname>Gajkowska</surname><given-names>B.</given-names></name><name><surname>Cholewinski</surname><given-names>M.</given-names></name><name><surname>Blomgren</surname><given-names>K.</given-names></name><name><surname>Lazarewicz</surname><given-names>J. W.</given-names></name><name><surname>Hagberg</surname><given-names>H.</given-names></name></person-group> (<year>2000</year>). <article-title>Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats</article-title>. <source/>Brain Res. Dev. Brain Res.
<volume>125</volume>, <fpage>31</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-3806(00)00110-3</pub-id><pub-id pub-id-type="pmid">11154758</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>F.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>296</volume>, <fpage>C250</fpage>–<lpage>C255</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00433.2008</pub-id><pub-id pub-id-type="pmid">18945939</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retamal</surname><given-names>M. A.</given-names></name><name><surname>Froger</surname><given-names>N.</given-names></name><name><surname>Palacios-Prado</surname><given-names>N.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Sáez</surname><given-names>P. J.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>13781</fpage>–<lpage>13792</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2042-07.2007</pub-id><pub-id pub-id-type="pmid">18077690</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>J. E.</given-names></name><name><surname>Vannucci</surname><given-names>R. C.</given-names></name><name><surname>Brierley</surname><given-names>J. B.</given-names></name></person-group> (<year>1981</year>). <article-title>The influence of immaturity on hypoxic-ischemic brain damage in the rat</article-title>. <source/>Ann. Neurol.
<volume>9</volume>, <fpage>131</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410090206</pub-id><pub-id pub-id-type="pmid">7235629</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riquelme</surname><given-names>M. A.</given-names></name><name><surname>Cea</surname><given-names>L. A.</given-names></name><name><surname>Vega</surname><given-names>J. L.</given-names></name><name><surname>Boric</surname><given-names>M. P.</given-names></name><name><surname>Monyer</surname><given-names>H.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The ATP required for potentiation of skeletal muscle contraction is released via pannexin hemichannels</article-title>. <source/>Neuropharmacology
<volume>75</volume>, <fpage>594</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.03.022</pub-id><pub-id pub-id-type="pmid">23583931</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanko</surname><given-names>M. J.</given-names></name><name><surname>Rothstein</surname><given-names>R. P.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Neural stem cells in the subventricular zone are resilient to hypoxia/ischemia whereas progenitors are vulnerable</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>24</volume>, <fpage>814</fpage>–<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1097/01.WCB.0000123906.17746.00</pub-id><pub-id pub-id-type="pmid">15241190</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>J.</given-names></name><name><surname>Muñiz</surname><given-names>J.</given-names></name><name><surname>Logica Tornatore</surname><given-names>T.</given-names></name><name><surname>Holubiec</surname><given-names>M.</given-names></name><name><surname>Gonzalez</surname><given-names>J.</given-names></name><name><surname>Barreto</surname><given-names>G. E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Dual role of astrocytes in perinatal asphyxia injury and neuroprotection</article-title>. <source/>Neurosci. Lett.
<volume>565</volume>, <fpage>42</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.10.046</pub-id><pub-id pub-id-type="pmid">24172702</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>D.</given-names></name><name><surname>Volterra</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Astrocytic dysfunction: insights on the role in neurodegeneration</article-title>. <source/>Brain Res. Bull.
<volume>80</volume>, <fpage>224</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2009.07.012</pub-id><pub-id pub-id-type="pmid">19631259</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothstein</surname><given-names>J. D.</given-names></name><name><surname>Martin</surname><given-names>L.</given-names></name><name><surname>Levey</surname><given-names>A. I.</given-names></name><name><surname>Dykes-Hoberg</surname><given-names>M.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Localization of neuronal and glial glutamate transporters</article-title>. <source/>Neuron
<volume>13</volume>, <fpage>713</fpage>–<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(94)90038-8</pub-id><pub-id pub-id-type="pmid">7917301</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sáez</surname><given-names>J. C.</given-names></name><name><surname>Retamal</surname><given-names>M. A.</given-names></name><name><surname>Basilio</surname><given-names>D.</given-names></name><name><surname>Bukauskas</surname><given-names>F. F.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name></person-group> (<year>2005</year>). <article-title>Connexin-based gap junction hemichannels: gating mechanisms</article-title>. <source/>Biochim. Biophys. Acta
<volume>1711</volume>, <fpage>215</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2005.01.014</pub-id><pub-id pub-id-type="pmid">15955306</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago</surname><given-names>M. F.</given-names></name><name><surname>Veliskova</surname><given-names>J.</given-names></name><name><surname>Patel</surname><given-names>N. K.</given-names></name><name><surname>Lutz</surname><given-names>S. E.</given-names></name><name><surname>Caille</surname><given-names>D.</given-names></name><name><surname>Charollais</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Targeting pannexin1 improves seizure outcome</article-title>. <source/>PLoS ONE
<volume>6</volume>:<fpage>e25178</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0025178</pub-id><pub-id pub-id-type="pmid">21949881</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schalper</surname><given-names>K. A.</given-names></name><name><surname>Sanchez</surname><given-names>H. A.</given-names></name><name><surname>Lee</surname><given-names>S. C.</given-names></name><name><surname>Altenberg</surname><given-names>G. A.</given-names></name><name><surname>Nathanson</surname><given-names>M. H.</given-names></name><name><surname>Saez</surname><given-names>J. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Connexin 43 hemichannels mediate the Ca<sup>2+</sup> influx induced by extracellular alkalinization</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>299</volume>, <fpage>C1504</fpage>–<lpage>C1515</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00015.2010</pub-id><pub-id pub-id-type="pmid">20881238</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankaran</surname><given-names>S.</given-names></name><name><surname>Laptook</surname><given-names>A. R.</given-names></name><name><surname>Ehrenkranz</surname><given-names>R. A.</given-names></name><name><surname>Tyson</surname><given-names>J. E.</given-names></name><name><surname>Mcdonald</surname><given-names>S. A.</given-names></name><name><surname>Donovan</surname><given-names>E. F.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy</article-title>. <source/>N. Engl. J. Med.
<volume>353</volume>, <fpage>1574</fpage>–<lpage>1584</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMcps050929</pub-id><pub-id pub-id-type="pmid">16221780</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>B. Z.</given-names></name><name><surname>Cao</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Targeting NLRP3 inflammasome in the treatment of CNS diseases</article-title>. <source/>Front. Mol. Neurosci.
<volume>11</volume>:<fpage>320</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00320</pub-id><pub-id pub-id-type="pmid">30233319</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A. A.</given-names></name><name><surname>Jen</surname><given-names>R.</given-names></name><name><surname>Kan</surname><given-names>B.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Marchant</surname><given-names>E.</given-names></name><name><surname>Tang</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Impaired NLRP3 inflammasome activity during fetal development regulates IL-1beta production in human monocytes</article-title>. <source/>Eur. J. Immunol.
<volume>45</volume>, <fpage>238</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201444707</pub-id><pub-id pub-id-type="pmid">25311115</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhan</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name><name><surname>Fina</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component</article-title>. <source/>Nat. Immunol.
<volume>17</volume>, <fpage>250</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3333</pub-id><pub-id pub-id-type="pmid">26642356</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Pei</surname><given-names>L.</given-names></name><name><surname>Yao</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Shang</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>NLRP3 inflammasome in neurological diseases, from functions to therapies</article-title>. <source/>Front. Cell. Neurosci.
<volume>11</volume>:<fpage>63</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00063</pub-id><pub-id pub-id-type="pmid">28337127</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stokes</surname><given-names>L.</given-names></name><name><surname>Layhadi</surname><given-names>J. A.</given-names></name><name><surname>Bibic</surname><given-names>L.</given-names></name><name><surname>Dhuna</surname><given-names>K.</given-names></name><name><surname>Fountain</surname><given-names>S. J.</given-names></name></person-group> (<year>2017</year>). <article-title>P2X4 receptor function in the nervous system and current breakthroughs in pharmacology</article-title>. <source/>Front. Pharmacol
<volume>8</volume>:<fpage>291</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00291</pub-id><pub-id pub-id-type="pmid">28588493</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stout</surname><given-names>C. E.</given-names></name><name><surname>Costantin</surname><given-names>J. L.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><name><surname>Charles</surname><given-names>A. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels</article-title>. <source/>J. Biol. Chem.
<volume>277</volume>, <fpage>10482</fpage>–<lpage>10488</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109902200</pub-id><pub-id pub-id-type="pmid">11790776</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strunk</surname><given-names>T.</given-names></name><name><surname>Currie</surname><given-names>A.</given-names></name><name><surname>Richmond</surname><given-names>P.</given-names></name><name><surname>Simmer</surname><given-names>K.</given-names></name><name><surname>Burgner</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Innate immunity in human newborn infants: prematurity means more than immaturity</article-title>. <source/>J. Matern. Fetal Neonatal Med.
<volume>24</volume>, <fpage>25</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2010.482605</pub-id><pub-id pub-id-type="pmid">20569168</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>S. M.</given-names></name><name><surname>Björkman</surname><given-names>S. T.</given-names></name><name><surname>Miller</surname><given-names>S. M.</given-names></name><name><surname>Colditz</surname><given-names>P. B.</given-names></name><name><surname>Pow</surname><given-names>D. V.</given-names></name></person-group> (<year>2010</year>). <article-title>Morphological changes in white matter astrocytes in response to hypoxia/ischemia in the neonatal pig</article-title>. <source/>Brain Res.
<volume>1319</volume>, <fpage>164</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.01.010</pub-id><pub-id pub-id-type="pmid">20079338</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surprenant</surname><given-names>A.</given-names></name><name><surname>North</surname><given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Signaling at purinergic P2X receptors</article-title>. <source/>Annu. Rev. Physiol.
<volume>71</volume>, <fpage>333</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.70.113006.100630</pub-id><pub-id pub-id-type="pmid">18851707</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suurväli</surname><given-names>J.</given-names></name><name><surname>Boudinot</surname><given-names>P.</given-names></name><name><surname>Kanellopoulos</surname><given-names>J.</given-names></name><name><surname>Ruutel Boudinot</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>P2X4: A fast and sensitive purinergic receptor</article-title>. <source/>Biomed. J.
<volume>40</volume>, <fpage>245</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/j.bj.2017.06.010</pub-id><pub-id pub-id-type="pmid">29179879</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Pattern recognition receptors and inflammation</article-title>. <source/>Cell
<volume>140</volume>, <fpage>805</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id><pub-id pub-id-type="pmid">20303872</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>T.</given-names></name><name><surname>Lang</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Gong</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation</article-title>. <source/>Nat. Commun.
<volume>8</volume>:<fpage>202</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-00227-x</pub-id><pub-id pub-id-type="pmid">28779175</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theis</surname><given-names>M.</given-names></name><name><surname>Sohl</surname><given-names>G.</given-names></name><name><surname>Eiberger</surname><given-names>J.</given-names></name><name><surname>Willecke</surname><given-names>K.</given-names></name></person-group> (<year>2005</year>). <article-title>Emerging complexities in identity and function of glial connexins</article-title>. <source/>Trends Neurosci.
<volume>28</volume>, <fpage>188</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2005.02.006</pub-id><pub-id pub-id-type="pmid">15808353</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>R. J.</given-names></name><name><surname>Jackson</surname><given-names>M. F.</given-names></name><name><surname>Olah</surname><given-names>M. E.</given-names></name><name><surname>Rungta</surname><given-names>R. L.</given-names></name><name><surname>Hines</surname><given-names>D. J.</given-names></name><name><surname>Beazely</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus</article-title>. <source/>Science
<volume>322</volume>, <fpage>1555</fpage>–<lpage>1559</lpage>. <pub-id pub-id-type="doi">10.1126/science.1165209</pub-id><pub-id pub-id-type="pmid">19056988</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>R. J.</given-names></name><name><surname>Zhou</surname><given-names>N.</given-names></name><name><surname>Macvicar</surname><given-names>B. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Ischemia opens neuronal gap junction hemichannels</article-title>. <source/>Science
<volume>312</volume>, <fpage>924</fpage>–<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1126/science.1126241</pub-id><pub-id pub-id-type="pmid">16690868</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname><given-names>J. S.</given-names></name><name><surname>Ordidge</surname><given-names>R. J.</given-names></name><name><surname>Penrice</surname><given-names>J.</given-names></name><name><surname>Cady</surname><given-names>E. B.</given-names></name><name><surname>Amess</surname><given-names>P. N.</given-names></name><name><surname>Punwani</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Temporal and anatomical variations of brain water apparent diffusion coefficient in perinatal cerebral hypoxic-ischemic injury: relationships to cerebral energy metabolism</article-title>. <source/>Magn. Reson. Med.
<volume>39</volume>, <fpage>920</fpage>–<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.1910390609</pub-id><pub-id pub-id-type="pmid">9621915</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ting</surname><given-names>J. P.</given-names></name><name><surname>Lovering</surname><given-names>R. C.</given-names></name><name><surname>Alnemri</surname><given-names>E. S.</given-names></name><name><surname>Bertin</surname><given-names>J.</given-names></name><name><surname>Boss</surname><given-names>J. M.</given-names></name><name><surname>Davis</surname><given-names>B. K.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>The NLR gene family: a standard nomenclature</article-title>. <source/>Immunity
<volume>28</volume>, <fpage>285</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2008.02.005</pub-id><pub-id pub-id-type="pmid">18341998</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonkin</surname><given-names>R. S.</given-names></name><name><surname>Bowles</surname><given-names>C.</given-names></name><name><surname>Perera</surname><given-names>C. J.</given-names></name><name><surname>Keating</surname><given-names>B. A.</given-names></name><name><surname>Makker</surname><given-names>P. G. S.</given-names></name><name><surname>Duffy</surname><given-names>S. S.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Attenuation of mechanical pain hypersensitivity by treatment with Peptide5, a connexin-43 mimetic peptide, involves inhibition of NLRP3 inflammasome in nerve-injured mice</article-title>. <source/>Exp. Neurol.
<volume>300</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2017.10.016</pub-id><pub-id pub-id-type="pmid">29055716</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>M. D.</given-names></name><name><surname>Nedjai</surname><given-names>B.</given-names></name><name><surname>Hurst</surname><given-names>T.</given-names></name><name><surname>Pennington</surname><given-names>D. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease</article-title>. <source/>Biochim. Biophys. Acta
<volume>1843</volume>, <fpage>2563</fpage>–<lpage>2582</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.05.014</pub-id><pub-id pub-id-type="pmid">24892271</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unger</surname><given-names>V. M.</given-names></name><name><surname>Kumar</surname><given-names>N. M.</given-names></name><name><surname>Gilula</surname><given-names>N. B.</given-names></name><name><surname>Yeager</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>Three-dimensional structure of a recombinant gap junction membrane channel</article-title>. <source/>Science
<volume>283</volume>, <fpage>1176</fpage>–<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.1126/science.283.5405.1176</pub-id><pub-id pub-id-type="pmid">10024245</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Heuij</surname><given-names>L. G.</given-names></name><name><surname>Fraser</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>S. L.</given-names></name><name><surname>Jenkin</surname><given-names>G.</given-names></name><name><surname>Wallace</surname><given-names>E. M.</given-names></name><name><surname>Davidson</surname><given-names>J. O.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Delayed intranasal infusion of human amnion epithelial cells improves white matter maturation after asphyxia in preterm fetal sheep</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>39</volume>, <fpage>223</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X17729954</pub-id><pub-id pub-id-type="pmid">28895475</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vannucci</surname><given-names>R. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Hypoxic-ischemic encephalopathy</article-title>. <source/>Am. J. Perinatol.
<volume>17</volume>, <fpage>113</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1055/s-2000-9293</pub-id><pub-id pub-id-type="pmid">11012134</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>R.</given-names></name><name><surname>Cronin</surname><given-names>C. G.</given-names></name><name><surname>Hudobenko</surname><given-names>J.</given-names></name><name><surname>Venna</surname><given-names>V. R.</given-names></name><name><surname>Mccullough</surname><given-names>L. D.</given-names></name><name><surname>Liang</surname><given-names>B. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke</article-title>. <source/>Brain. Behav. Immun.
<volume>66</volume>, <fpage>302</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2017.07.155</pub-id><pub-id pub-id-type="pmid">28751018</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>A.</given-names></name><name><surname>Hormuzdi</surname><given-names>S. G.</given-names></name><name><surname>Monyer</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Pannexin1 and Pannexin2 expression in the developing and mature rat brain</article-title>. <source/>Brain Res. Mol. Brain Res.
<volume>141</volume>, <fpage>113</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbrainres.2005.08.002</pub-id><pub-id pub-id-type="pmid">16143426</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallisch</surname><given-names>J. S.</given-names></name><name><surname>Simon</surname><given-names>D. W.</given-names></name><name><surname>Bayir</surname><given-names>H.</given-names></name><name><surname>Bell</surname><given-names>M. J.</given-names></name><name><surname>Kochanek</surname><given-names>P. M.</given-names></name><name><surname>Clark</surname><given-names>R. S. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children</article-title>. <source/>Neurocrit. Care
<volume>27</volume>, <fpage>44</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s12028-017-0378-7</pub-id><pub-id pub-id-type="pmid">28181102</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallraff</surname><given-names>A.</given-names></name><name><surname>Kohling</surname><given-names>R.</given-names></name><name><surname>Heinemann</surname><given-names>U.</given-names></name><name><surname>Theis</surname><given-names>M.</given-names></name><name><surname>Willecke</surname><given-names>K.</given-names></name><name><surname>Steinhauser</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>5438</fpage>–<lpage>5447</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0037-06.2006</pub-id><pub-id pub-id-type="pmid">16707796</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Y. G.</given-names></name><name><surname>Lyu</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>Z. W.</given-names></name><name><surname>Zhang</surname><given-names>J. N.</given-names></name></person-group> (<year>2018</year>). <article-title>Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms</article-title>. <source/>Neural Regen. Res.
<volume>13</volume>, <fpage>819</fpage>–<lpage>826</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.232529</pub-id><pub-id pub-id-type="pmid">29863012</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>A.</given-names></name><name><surname>Xi</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Connexin 43 and its hemichannels mediate hypoxia-ischemia-induced cell death in neonatal rats</article-title>. <source/>Child Neurol. Open
<volume>1</volume>:<fpage>2329048X</fpage>14544955. <pub-id pub-id-type="doi">10.1177/2329048X14544955</pub-id><pub-id pub-id-type="pmid">28503580</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Jacobsen</surname><given-names>S. E.</given-names></name><name><surname>Bengtsson</surname><given-names>A.</given-names></name><name><surname>Erlinge</surname><given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34<sup>+</sup> stem and progenitor cells</article-title>. <source/>BMC Immunol.
<volume>5</volume>:<fpage>16</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2172-5-16</pub-id><pub-id pub-id-type="pmid">15291969</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>De Bock</surname><given-names>M.</given-names></name><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>Bol</surname><given-names>M.</given-names></name><name><surname>Gadicherla</surname><given-names>A.</given-names></name><name><surname>Bultynck</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Connexin targeting peptides as inhibitors of voltage- and intracellular Ca<sup>2+</sup>-triggered Cx43 hemichannel opening</article-title>. <source/>Neuropharmacology
<volume>75</volume>, <fpage>506</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.08.021</pub-id><pub-id pub-id-type="pmid">24007825</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Dhillon</surname><given-names>S. K.</given-names></name><name><surname>Fraser</surname><given-names>M.</given-names></name><name><surname>Galinsky</surname><given-names>R.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Partial white and grey matter protection with prolonged infusion of recombinant human erythropoietin after asphyxia in preterm fetal sheep</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>37</volume>, <fpage>1080</fpage>–<lpage>1094</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X16650455</pub-id><pub-id pub-id-type="pmid">27207167</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Lear</surname><given-names>C. A.</given-names></name><name><surname>Juul</surname><given-names>S. E.</given-names></name><name><surname>Northington</surname><given-names>F.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>A working model for hypothermic neuroprotection</article-title>. <source/>J. Physiol.
<volume>596</volume>, <fpage>5641</fpage>–<lpage>5654</lpage>
<pub-id pub-id-type="doi">10.1113/JP274928</pub-id><pub-id pub-id-type="pmid">29660115</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassink</surname><given-names>G.</given-names></name><name><surname>Gunn</surname><given-names>E. R.</given-names></name><name><surname>Drury</surname><given-names>P. P.</given-names></name><name><surname>Bennet</surname><given-names>L.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>The mechanisms and treatment of asphyxial encephalopathy</article-title>. <source/>Front. Neurosci.
<volume>8</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2014.00040</pub-id><pub-id pub-id-type="pmid">24578682</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>B.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Du</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Probenecid protects against cerebral ischemia/reperfusion injury by inhibiting lysosomal and inflammatory damage in rats</article-title>. <source/>Neuroscience
<volume>301</volume>, <fpage>168</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.05.070</pub-id><pub-id pub-id-type="pmid">26047730</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weilinger</surname><given-names>N. L.</given-names></name><name><surname>Tang</surname><given-names>P. L.</given-names></name><name><surname>Thompson</surname><given-names>R. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Anoxia-induced NMDA receptor activation opens pannexin channels via Src family kinases</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>12579</fpage>–<lpage>12588</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1267-12.2012</pub-id><pub-id pub-id-type="pmid">22956847</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willebrords</surname><given-names>J.</given-names></name><name><surname>Crespo Yanguas</surname><given-names>S.</given-names></name><name><surname>Maes</surname><given-names>M.</given-names></name><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Leybaert</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Connexins and their channels in inflammation</article-title>. <source/>Crit. Rev. Biochem. Mol. Biol.
<volume>51</volume>, <fpage>413</fpage>–<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1080/10409238.2016.1204980</pub-id><pub-id pub-id-type="pmid">27387655</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C. E.</given-names></name><name><surname>Gunn</surname><given-names>A.</given-names></name><name><surname>Gluckman</surname><given-names>P. D.</given-names></name></person-group> (<year>1991</year>). <article-title>Time course of intracellular edema and epileptiform activity following prenatal cerebral ischemia in sheep</article-title>. <source/>Stroke
<volume>22</volume>, <fpage>516</fpage>–<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.22.4.516</pub-id><pub-id pub-id-type="pmid">2024281</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C. E.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Gluckman</surname><given-names>P. D.</given-names></name></person-group> (<year>1992</year>). <article-title>Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study</article-title>. <source/>Ann. Neurol.
<volume>31</volume>, <fpage>14</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410310104</pub-id><pub-id pub-id-type="pmid">1543346</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C. E.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name><name><surname>Gluckman</surname><given-names>P. D.</given-names></name></person-group> (<year>1993</year>). <article-title>Pathophysiology of perinatal asphyxia</article-title>. <source/>Clin. Perinatol.
<volume>20</volume>, <fpage>305</fpage>–<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1016/S0095-5108(18)30395-6</pub-id><pub-id pub-id-type="pmid">8358953</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winerdal</surname><given-names>M.</given-names></name><name><surname>Winerdal</surname><given-names>M. E.</given-names></name><name><surname>Kinn</surname><given-names>J.</given-names></name><name><surname>Urmaliya</surname><given-names>V.</given-names></name><name><surname>Winqvist</surname><given-names>O.</given-names></name><name><surname>Aden</surname><given-names>U.</given-names></name></person-group> (<year>2012</year>). <article-title>Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e36422</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0036422</pub-id><pub-id pub-id-type="pmid">22567156</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wixey</surname><given-names>J. A.</given-names></name><name><surname>Reinebrant</surname><given-names>H. E.</given-names></name><name><surname>Carty</surname><given-names>M. L.</given-names></name><name><surname>Buller</surname><given-names>K. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Delayed P2X4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain</article-title>. <source/>J. Neuroimmunol.
<volume>212</volume>, <fpage>35</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2009.04.016</pub-id><pub-id pub-id-type="pmid">19447505</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname><given-names>L. R.</given-names></name><name><surname>Godar</surname><given-names>S. C.</given-names></name><name><surname>Khoja</surname><given-names>S.</given-names></name><name><surname>Jakowec</surname><given-names>M. W.</given-names></name><name><surname>Alkana</surname><given-names>R. L.</given-names></name><name><surname>Bortolato</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Sociocommunicative and sensorimotor impairments in male P2X4-deficient mice</article-title>. <source/>Neuropsychopharmacology
<volume>38</volume>, <fpage>1993</fpage>–<lpage>2002</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2013.98</pub-id><pub-id pub-id-type="pmid">23604007</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>J. L.</given-names></name><name><surname>Wong</surname><given-names>H. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Pathophysiology and treatment of septic shock in neonates</article-title>. <source/>Clin. Perinatol.
<volume>37</volume>, <fpage>439</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1016/j.clp.2010.04.002</pub-id><pub-id pub-id-type="pmid">20569817</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Yin</surname><given-names>D.</given-names></name><name><surname>Ren</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury</article-title>. <source/>Neurobiol. Dis.
<volume>117</volume>, <fpage>15</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2018.05.016</pub-id><pub-id pub-id-type="pmid">29859317</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Khadra</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Tomic</surname><given-names>M.</given-names></name><name><surname>Sherman</surname><given-names>A.</given-names></name><name><surname>Stojilkovic</surname><given-names>S. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Experimental characterization and mathematical modeling of P2X7 receptor channel gating</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>14213</fpage>–<lpage>14224</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2390-10.2010</pub-id><pub-id pub-id-type="pmid">20962242</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Tomic</surname><given-names>M.</given-names></name><name><surname>Stojilkovic</surname><given-names>S. S.</given-names></name></person-group> (<year>2008</year>). <article-title>The P2X7 receptor channel pore dilates under physiological ion conditions</article-title>. <source/>J. Gen. Physiol.
<volume>132</volume>, <fpage>563</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200810059</pub-id><pub-id pub-id-type="pmid">18852304</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>T.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Bao</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse</article-title>. <source/>Exp. Neurol.
<volume>292</volume>, <fpage>46</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2017.03.002</pub-id><pub-id pub-id-type="pmid">28274860</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Z. C.</given-names></name><name><surname>Wyeth</surname><given-names>M. S.</given-names></name><name><surname>Baltan-Tekkok</surname><given-names>S.</given-names></name><name><surname>Ransom</surname><given-names>B. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Functional hemichannels in astrocytes: a novel mechanism of glutamate release</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>3588</fpage>–<lpage>3596</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-09-03588.2003</pub-id><pub-id pub-id-type="pmid">12736329</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>C.</given-names></name><name><surname>Mei</surname><given-names>X.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Mato</surname><given-names>S.</given-names></name><name><surname>Matias</surname><given-names>I.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease</article-title>. <source/>Cell Death Differ.
<volume>23</volume>, <fpage>1691</fpage>–<lpage>1701</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2016.63</pub-id><pub-id pub-id-type="pmid">27391799</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>D.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2018a</year>). <article-title>Dexmedetomidine attenuated early brain injury in rats with subarachnoid haemorrhage by suppressing the inflammatory response: the TLR4/NF-kappaB pathway and the NLRP3 inflammasome may be involved in the mechanism</article-title>. <source/>Brain Res.
<volume>1698</volume>, <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2018.05.040</pub-id><pub-id pub-id-type="pmid">29842860</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>D.</given-names></name><name><surname>Yin</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Hou</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2018b</year>). <article-title>Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone</article-title>. <source/>J. Neuroinflammation
<volume>15</volume>:<fpage>97</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-018-1127-3</pub-id><pub-id pub-id-type="pmid">29587860</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ystgaard</surname><given-names>M. B.</given-names></name><name><surname>Sejersted</surname><given-names>Y.</given-names></name><name><surname>Loberg</surname><given-names>E. M.</given-names></name><name><surname>Lien</surname><given-names>E.</given-names></name><name><surname>Yndestad</surname><given-names>A.</given-names></name><name><surname>Saugstad</surname><given-names>O. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Early upregulation of NLRP3 in the brain of neonatal mice exposed to hypoxia-ischemia: no early neuroprotective effects of NLRP3 deficiency</article-title>. <source/>Neonatology
<volume>108</volume>, <fpage>211</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1159/000437247</pub-id><pub-id pub-id-type="pmid">26279061</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Q.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Ouyang</surname><given-names>Q.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Block of P2X7 receptors could partly reverse the delayed neuronal death in area CA1 of the hippocampus after transient global cerebral ischemia</article-title>. <source/>Purinergic Signal.
<volume>9</volume>, <fpage>663</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1007/s11302-013-9379-y</pub-id><pub-id pub-id-type="pmid">23877788</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zasada</surname><given-names>M.</given-names></name><name><surname>Lenart</surname><given-names>M.</given-names></name><name><surname>Rutkowska-Zapala</surname><given-names>M.</given-names></name><name><surname>Stec</surname><given-names>M.</given-names></name><name><surname>Mol</surname><given-names>N.</given-names></name><name><surname>Czyz</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Analysis of selected aspects of inflammasome function in the monocytes from neonates born extremely and very prematurely</article-title>. <source/>Immunobiology
<volume>223</volume>, <fpage>18</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2017.10.019</pub-id><pub-id pub-id-type="pmid">29042061</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeinieh</surname><given-names>M. P.</given-names></name><name><surname>Talhouk</surname><given-names>R. S.</given-names></name><name><surname>El-Sabban</surname><given-names>M. E.</given-names></name><name><surname>Mikati</surname><given-names>M. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Differential expression of hippocampal connexins after acute hypoxia in the developing brain</article-title>. <source/>Brain Dev.
<volume>32</volume>, <fpage>810</fpage>–<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2009.11.003</pub-id><pub-id pub-id-type="pmid">20034754</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H. B.</given-names></name><name><surname>Yu</surname><given-names>N.</given-names></name><name><surname>Fleming</surname><given-names>C. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Gap junctional hemichannel-mediated ATP release and hearing controls in the inner ear</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>102</volume>, <fpage>18724</fpage>–<lpage>18729</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506481102</pub-id><pub-id pub-id-type="pmid">16344488</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>